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THE AGONY OF ECSTASY: RECONSIDERING
THE PUNITIVE APPROACH TO UNITED
STATES DRUG POLICY
Amanda Kay*
INTRODUCTION
People think they can stop the drug traffic by putting people in
jail and by having terribly long sentences. But, of course, it
doesn't do any good.'
-Judge Whitman Knapp
In the past few years, legislators and judges have become more
vocal in their opposition to the "war on drugs"2 in the United
States.' However, challenging punitive drug laws is politically diffi-
* J.D. Candidate, Fordham University School of Law, 2003; B.A., College of
Liberal Arts, University of Maryland, 1997. I would like to thank Elizabeth Cooper,
Associate Professor of Law, Fordham University School of Law, for her guidance and
support in the development of this Comment. I would also like to thank Andy Ko,
Director, ACLU of Washington Drug Policy Reform Project, for planting the seed
which grew into this Comment. Finally, I would like to thank the editorial board and
staff of the Fordham Urban Law Journal, especially Gail Glidewell, for their invalua-
ble time, effort, and support.
1. JAMES P. GRAY, WHY OUR DRUG LAWS HAVE FAILED AND WHAT WE CAN
Do ABOUT IT: A JUDICIAL INDICTMENT OF THE WAR ON DRUGS 19 (2001) (quoting
Senior Judge Whitman Knapp, United States District Court, Southern District of New
York).
2. DAVID SADOFSKY BAGGINS, DRUG HATE AND THE CORRUPTION OF AMERI-
CAN JUSTICE 98-99 (1998) (stating that former President George Bush's Drug Czar,
Bob Martinez, declared that the drug war was about stomping out the wrong culture
because "drug use is wrong. And the moral argument in the end is the most compel-
ling argument."); ERICH GOODE, Preface, in BETWEEN POLITICS AND REASON: THE
DRUG LEGALIZATION DEBATE viii (Erich Goode ed., 1997) ("Since 1981, with the
administration of President Ronald Reagan, the United States has been waging a
'War on Drugs.'"); GRAY, supra note 1, at 27 ("Richard M. Nixon [was] the first U.S.
president formally to declare the nation's 'War on Drugs."'); Mary Thornton, Admin-
istration Attack on Drug's Criticized by DEA Directory, WASH. POST, May 15, 1984, at
A13 (stating that the Reagan administration tried to "wage a war on drugs"). The
"war on drugs" describes the United States' drug policy of the past three decades.
Frontline Teachers' Guide - Drug Wars at http://www.pbs.org/wgbh/pages/frontline/
teach/american/drugs (last visited Apr. 25, 2002). It began with Former President
Nixon's declaration that illegal drug consumption is public enemy number one, and
that an all out war on drugs was necessary. Id. After his declaration, the federal gov-
ernment applied a new zeal to the four components of this war: (1) treatment; (2) law
enforcement; (3) eradication; and (4) interdiction. President Nixon also established
the Drug Enforcement Agency. Id.
3. E.g., GRAY, supra note 1, at 1 ("I had seen that our drug laws were a failure,
and I simply could not keep quiet about it any longer."); Arianna Huffington, The
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cult; the challenger risks being perceived by the public as someone
"weak on crime" who "condones drug use."4 Tom Campbell, a
congressman from California, commented on this phenomenon:
"The most common reaction I get from my colleagues is 'You're
absolutely right, but, boy, I'm not going to take that risk." 5 While
the public is decreasingly supportive of punitive laws,6 many still
cling to the belief that such laws will reduce drug use because of
fear-fear that drug use among children will increase and that less
stringent drug laws will lead to moral decline and empower minor-
ity groups.7
War On Drugs: Just Say 'No More,' ARIANNA ON LINE, June 1, 2000, at http://
www.ariannaonline.com/columns/files/O6010O.html (last visited Apr. 25, 2002) (stating
that Representative Jan Schakowsky (D-IL) said, "There is a growing acknowledg-
ment that the drug war hasn't worked," and that Representative Ron Paul (R-TX)
declared, "The war on drugs is a total failure. It does more harm than good").
4. See GRAY, supra note 1, at 28 (stating that our political system rewards politi-
cians who posture as being "tough on drugs"); Nicholas Katzenbach, Drug Policy and
the Rule of Law, 28 FORDHAM URB. L.J. 172, 173 (2000) ("[T]o a surprising degree,
politicians have acted as though ... the answer to our fear is simply to be 'tough.' Any
politician who is viewed as 'soft' on crime is likely to be in trouble."); Andrew Fried-
man, A New Day, VILLAGE VOICE, Nov. 8, 2000, at 59 ("Afraid of being labeled weak
on crime, many politicians have been reluctant to push for relaxing the Rockefeller
code.").
5. Huffington, supra note 3.
6. Drug War Report, (The Pew Research Ctr. for the People and the Press, Wash-
ington, D.C.), Mar. 21, 2001, at http://208.240.91.18/drugs01rpt.htm (last visited May 3,
2002) (noting that in a national opinion poll, seventy-four percent of Americans see
the War on Drugs as a losing cause, and fifty-two percent believe that drug use should
be treated as a disease).
7. GRAY, supra note 1, at 6 (explaining that drug use has been treated as a moral
issue in the United States for several decades, and this is why people resist awareness
of the damages caused by drug policy itself); DAVID MUSTO, THE AMERICAN Dis-
EASE 294-95 (Oxford University Press, 1999) (1973) (stating that the strongest support
for drug prohibition has been associated with fear of a given drug's effect on a minor-
ity group as demonstrated by the prohibition of cocaine for fear that it would enable
blacks to withstand bullets, the prohibition of opium for fear that it would stimulate
sexual contact between Chinese and white Americans, and the prohibition of alcohol
for fear that it would encourage immigrants to crowd into large cities); Timothy
Lynch, War No More, NAT'L REV., Feb. 5, 2001, at 4041 (stating that supporters of the
drug war defend their position by claiming that "Drug use is wrong. It is wrong be-
cause it is immoral, and it is immoral because it degrades human beings"); Eileen
Smith, Drugs Top Adult Fears for Kids' Well-Being, USA TODAY, Dec. 9, 1997, at D1
(citing a study conducted by Harvard's School of Public Health and the University of
Maryland Survey Research Center showing that Americans believe drug abuse, more
than crime or the breakdown of home life, is the biggest danger facing children).
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United States drug laws implicate complex matters such as race,8
gender, 9 class, the national budget, 10 prison overcrowding," civil
liberties, 12 and the spread of diseases such as HIV/AIDS and hepa-
titis. 13 In fact, efforts to reduce drug use may cause more harm
than the drugs themselves.' 4 For example, increased funding for
enforcement of criminal drug laws couple with escalating criminal
sentences has led to a rise in drug related convictions and a signifi-
cant need for prison beds; the war on drugs has created and sup-
ported a prison-industrial complex that costs taxpayers over $24
billion per year. 5 Enforcement is often directed at racial minori-
8. Five times as many white people use drugs as black people, yet the majority of
drug offenders sent to prison are black. Human Rights Watch, Racial Disparities in the
War on Drugs, 2000, at http://www.hrw.org/campaigns/drugs/war/key-facts.htm (last
visited Apr. 25, 2002). Nationwide, one in every twenty black men over the age of
eighteen is in prison, as compared to one in every 180 white men. Id.
9. From 1986 (the year mandatory sentencing was enacted) to 1996, the number
of women sentenced to state prison for drug crimes increased tenfold. Not Part of My
Sentence: Violations of the Human Rights of Women in Custody (Amnesty Int'l), Mar.
1999, at 39, at http://www.amnesty-usa.org/rightsforall/women/ (last visited Apr. 25,
2002). In 1997, a U.S. Justice Department investigation of women's prisons concluded
that authorities failed to protect women from sexual misconduct by correctional of-
ficers and other staff. Id. From 1986 (the year mandatory sentencing was enacted) to
1996, the number of women sentenced to state prison for drug crimes increased ten-
fold. Id.
10. In 1999, the U.S. spent a record $147 billion for police protection, corrections,
and judicial and legal activities. This expenditure increased 309% from almost $36
billion in 1982. Discounting inflation, that represents a 145% increase in constant dol-
lars. SIDRA LEA GIFFORD, U.S. DEP'T OF JUSTICE, JUSTICE EXPENDITURE AND EM-
PLOYMENT IN THE UNITED STATES 1 (1999).
11. The overall U.S. incarceration rate is six times that of its nearest Western
counterparts. ELLIOT CURRIE, CRIME AND PUNISHMENT IN AMERICA 61 (1998).
12. A Lexis review of federal court decisions between January 1, 1990 and August
2, 1995, in which drug-courier profiles were used and the race of the suspect was
discernible, revealed that of sixty-three such cases, all but three suspects were minori-
ties: thirty-four were black, twenty-five were Hispanic, one was Asian, and three were
white. DAVID COLE, No EQUAL JUSTICE: RACE AND CLASS IN THE AMERICAN CRIM-
INAL JUSTICE SYSTEM 50 (1999).
13. In 1998, HIV infection became the fifth leading cause of death among persons
aged twenty-five to forty-four years. SHERRY L. MURPHY, CTRS. FOR DISEASE CON-
TROL, DEATHS: FINAL DATA FOR 1998 26 tbl. 8 (2000).
14. Ethan Nadelmann, Learning to Live With Drugs, WASH. POST, Nov. 2, 1999, at
A21 (stating that many "drug problems" are the results, not of drug use, but of prohi-
bitionist policies: "the violence, the corruption, the vast underground markets, the
diversion of ever increasing resources to criminal justice and military agencies, the
environmental harms of crop eradication programs and unregulated illicit crop pro-
duction, the enrichment and empowerment of organized and unorganized criminals,
and so much more").
15. See PHILLIP BEATTY, BARRY HOLMAN, & VINCENT SCHIRALDI, JUSTICE POL-
ICY INST., POOR PRESCRIPTION: THE COSTS OF IMPRISONING DRUG OFFENDERS IN
THE UNITED STATES 2 (2000), available at http://www.cjcj.org (estimating that Ameri-
cans would spend $24 billion to incarcerate non-violent offenders in 2001; the total
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ties and lower class communities; civil liberties are sacrificed in
cases of racial profiling, illegal searches, and excessive wiretap-
ping.' 6 The direct financial cost of the war on drugs is in the bil-
lions, with most of the national budget allocated for enforcement.1 7
The additional indirect costs are unknown. Yet needle exchange
programs aimed at reducing harm by slowing the spread of HIV/
AIDS 18 go without funding and often without legal authority to
operate. 19 These are merely a few examples of the collateral conse-
quences of the drug war.
cost spent on incarceration was estimated at $40 billion); Fox Butterfield, Number of
Inmates Reaches Record 1.8 Million, N.Y. TIMES, Mar. 15, 1999, at A14 (demonstrat-
ing the high cost of the increase in prison population that is attributable to an increas-
ing number of drug convictions for longer sentences); Eric Schlosser, The
Prison-Industrial Complex, THE ATLANTIC, Dec. 1998, at 51 (defining "prison-indus-
trial complex" as "a set of bureaucratic, political, and economic interests that en-
courage increased spending on imprisonment, regardless of the actual need").
16. GRAY, supra note 1, at 97 ("[I]t is widely understood by attorneys and legal
commentators that there is a 'drugs exception' to the Bill of Rights."); Ronald J. Os-
trow, Sentencing Study Sees Race Disparity, L.A. TIMES, Oct. 5, 1995, at Al (discuss-
ing the Sentencing Project's study claiming that public policies ostensibly designed to
control crime and drug abuse have contributed to racial disparity in the criminal jus-
tice system).
17. See OFFICE OF NAT'L DRUG CONTROL POLICY, NATIONAL DRUG CONTROL
BUDGET: EXECUTIVE SUMMARY, FISCAL YEAR 2002 (2002) ("In total, funding recom-
mended for FY 2002 is an estimated $19.2 billion, an increase of $1.1 billion over the
FY 2001 enacted level of $18.1 billion."). Sixty-seven percent of the drug control
budget is spent on supply reduction efforts to reduce the supply and availability of
illicit drugs by limiting cultivation, production, trafficking and distribution. RENSSE-
LAER LEE & RAPHAEL PERL, CRS ISSUE BRIEF: DRUG CONTROL: INTERNATIONAL
POLICY OPTIONS 2 (2002). In contrast, thirty-three percent is spent on demand reduc-
tion efforts to prevent the onset of drug use, help drug users break the habit, and
provide treatment through rehabilitation and social reintegration. BUREAU OF WEST-
ERN HEMISPHERE AFFAIRS, UNITED STATES SUPPORT FOR COLUMBIA 1 (2000). The
imbalance is even more apparent at the state and local levels, where an estimated
eighty percent of spending is devoted to enforcement. DRUG STRATEGIES, CRITICAL
CHOICES: MAKING DRUG POLICY AT THE STATE LEVEL 1 (2001).
18. Anne Barnard, Saving the Sinner from Condoms for Teens to Needles for Ad-
dicts, Doctors Try to Lead a Divided Public, BOSTON GLOBE, Feb. 13, 2001, at El
("The American Medical Association, the Centers for Disease Control and Preven-
tion and the Institute of Medicine all endorse needle exchange-when combined with
efforts to get people into treatment saying it reduces HIV infections without increas-
ing drug use."); Syringe Exchange Programs, IDU/HIV PREVENTION (Academy for
Educational Development, Washington, D.C.), June 2000, at 1 (stating that syringe
exchange is most cost-effective means of prevention of AIDS).
19. Sandra D. Lane, The Coming of Age of Needle Exchange: A History Through
1993, in HARM REDUCTION: NATIONAL AND INTERNATIONAL PERSPECTIVES 47, 59-63
(James A. Inciardi & Lana D. Harrison eds., 2000) (discussing the difficulty needle
exchange programs meet in securing legal authority to operate due to paraphernalia
laws, prescription laws, drug-free zone laws, and the lack of funding for such
programs).
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An objective cost/benefit analysis of the current drug policy is
difficult to ascertain. In 1999, Americans spent an estimated $63.2
billion on illicit drugs.20 Most of that spending was by hard-core
addicts, 2' a group that makes up less than one-quarter of the drug
users in this country, but consumes over two-thirds of the illegal
drugs.22 Given that drugs are less expensive and more widely avail-
able than ever before, 23 and that punitive drug laws have increas-
ingly negative social consequences,24 finding advantages of the
current approach is a challenge. One 'commentator believes the
important question about any drug control program is whether it
"contribute[s] materially to the reduction of drug use and drug-
related harms. '25 Whether there is a "material" difference de-
pends on whether "the effect is sizeable and, in particular, whether
it is sizeable compared to the costs. 26
Examining the effects of United States drug policy under this
rubric may prove frustrating. For example, more drug convictions
could mean a reduction in the number of drug dealers and addicts,
but could also mean that more people are using and selling drugs.
Fewer drug-related emergency room visits could mean that fewer
people are getting sick from using drugs. It could also indicate that
fewer people are seeking treatment for drug-related illnesses. Less
marijuana use among teenagers than in the past could mean that
they are using fewer drugs in general, or it could simply mean they
20. Frontline, Drug Wars: The Buyers, at http://www.pbs.org/wgbh/pages/frontline/
shows/drugs/buyers/whoare.html (last visited Apr. 25, 2002).
21. A hard core addict is commonly understood as a person who uses large quanti-
ties of drugs, who is addicted to the point that drug use interferes with the rest of his
or her life, and who compulsively uses drugs in the face of tremendous consequences.
Interview of Dr. Alan I. Leshner, Director, National Institute on Drug Abuse (Oct.
10, 2000), at http://www.mapinc.org/drugnews/v00/n1548/a05.html (last visited Feb. 1,
2002).
22. Frontline, supra note 20, at http://www.pbs.org/wgbh/pages/frontline/shows/
drugslbuyers/whoare.html (last visited Apr. 25, 2002) (reporting that heavy users of
cocaine consume seventy percent of all cocaine reported in the NHSDA, and hard
core heroin users account for an even larger percentage of heroin sales).
23. See generally Judge Rudolph J. Gerber, On Dispensing Injustice, 43 ARIZ. L.
REV. 135, 155 (2001) ("In 1997, General McCaffrey candidly admitted that 'if mea-
sured solely in terms of price and purity, cocaine, heroin, and marijuana prove to be
more available than they were a decade ago.'").
24. Nadelmann, supra note 14, at A21.
25. JONATHAN P. CAULKINS, Do DRUG PROHIBITION AND ENFORCEMENT
WORK? 1 (2000). The intense focus paid to drug-related harms is surprising, given that
the Government allows people to harm themselves in many ways without interfer-
ence. In fact, overeating and lack of exercise kills more people and disables far more
people than all illegal drugs. James Ostrowski, Thinking About Drug Legalization,
POLICY ANALYSIS (the Cato Institute, Washington, D.C.), May 25, 1989, at 71.
26. CAULKINS, supra note 25.
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are using more of other drugs. Even if the number of drug users
were known, that knowledge might not prove an effective measure
of the success of drug policy. 27 The effects of the drug war remain
open to interpretation, providing fuel for the politics of the debate.
Yet, as the drug war enters its thirtieth year, 8 public sentiment is
migrating toward frustration and disapproval of the present system;
many people claim that the war on drugs has simply failed.29
Solutions are proffered by proponents of two traditionally op-
posed ideologies. On one side of the debate are prohibitionists,
those advocating a punitive approach through the criminal justice
system, believing that tougher laws will deter new drug dealers and
users while removing current ones from society.30 Their opponents
are those advocating harm reduction,3' who believe that education,
prevention, and treatment reduce the harm caused by drug use-
harm, that is, to some extent, inevitable.32 Although legislators
have traditionally been on opposing sides of the debate, preserving
this dichotomy may no longer be a viable option. A relatively new
27. Peter Reuter, Drug Use Measures: What Are They Telling Us?, NAT'L INST. OF
JUSTICE J., Apr. 1999, at 12 (asserting that the prevalence of drug abuse cannot be
measured by the number of people simply using drugs).
28. GRAY, supra note 1, at 27 (noting that Richard Nixon first declared that the
nation was engaged in a "War on Drugs" in 1969).
29. Larry D. Hatfield, Drug War Approach Seen as Utter Failure/Survey Finds
Public Favors Treatment, S.F. CHRON., Mar. 21, 2001, at Al (discussing results of a
study conducted by the Pew Research Center for the People and the Press showing
that three-fourths of Americans think the war on drugs is being lost; they also believe,
however, that the government should still give top priority to arresting drug dealers
and stopping the importation of drugs).
30. The "criminal justice" approach is also known as the "punitive approach" or
"prohibition." Richard C. Boldt, Rehabilitative Punishment and the Drug Treatment
Court Movement, 76 WASH. U. L.Q. 1205, 1217-18 (1998); Christopher Mascharka,
Mandatory Minimum Sentence: Exemplifying the Law of Unintended Consequences,
28 FLA. ST. U. L. REV. 935, 968 (2001), Norval Morris, Teenage Violence and Drug
Use, 31 VAL. U. L. REV. 547, 547 (1997). Many refer to advocates of this approach as
"drug warriors" because of their endorsement of, and participation in, the war on
drugs. See, e.g., Sue Anne Pressley, Jeb Bush Urged To Reconsider Drug Law View,
WASH. POST, Feb. 1, 2002, at A6. Throughout this Comment, "prohibitionist" and
"advocate of the criminal justice approach" will be used interchangeably to refer to a
person endorsing the belief that the best approach to drug use is attempting to eradi-
cate it by setting strict penalties and providing the resources to enforce those
penalties.
31. James A. Inciardi & Lana D. Harrison, Introduction: The Concept of Harm
Reduction, in HARM REDUCTION: NATIONAL AND INTERNATIONAL PERSPECTIVES,
supra note 19, at vii-viii (defining harm reduction as a variety of programs and policies
that focus on reducing the consequences of psychoactive drug use).
32. See Ethan A. Nadelmann & Jann S. Wenner, Toward a Sane National Drug
Policy, ROLLING STONE, May 5, 1994, at 24-26 (stating that drug use has been a part
of civilization since its inception).
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drug that has been gaining popularity among American teenagers
demonstrates the impracticality of maintaining this policy divide.33
Ecstasy3" is a psychoactive drug 35 that has both harm reduction
advocates and prohibitionists scrambling for a better solution. Ec-
stasy topped the Government's list of substances "increasing
sharply" in 2001.36 Ecstasy-related emergency room visits in-
creased fifty-eight percent from 1999 to 2000.37 Most recently, in
July 2001, New York police confiscated one million Ecstasy pills in
what is reported to be the single largest ecstasy seizure in history.38
More alarming than Ecstasy's recent rise in popularity is that it
has been classified in the Controlled Substance Act's most restric-
tive category for over fifteen years.3 9 Both state and federal penal-
ties for possession, manufacture, and distribution of the drug have
been increasing over the past ten years.4 0 Public perception of Ec-
33. The subject matter of this Comment is Ecstasy, but many of the arguments
contained herein can be made about other drugs. In many respects this paper is about
the drug war.
34. "Ecstasy" is the commonly used street name for 3, 4 Methylenediox-
ymethamphetamine ("MDMA"). Julie Holland, Let X-MDMA, in ECSTASY: A COM-
PLETE GUIDE 7, 8 (Julie Holland ed., 2001). Throughout this Comment, I will
primarily refer to this substance as "Ecstasy" for clarity, even though the term "Ec-
stasy" often refers to a group of unknown drugs, or to MDMA that has been mixed
with other substances. Julie Holland, Giving MDMA to Human Volunteers in the
United States, in ECSTASY: A COMPLETE GUIDE, supra, at 332.
35. A psychoactive drug is one that "has a significant effect on mood or mental
state." RANDOM HOUSE WEBSTER'S COLLEGE DICTrIONARY 1089 (Random House
1995) (1991).
36. Marsha Rosenbaum, Telling Our Children What We Know About Ecstasy, SAN
DIEGO UNION-TRIB., Aug. 9, 2001, at B1l (citing NAT'L INST. ON DRUG ABUSE,
DEP'T OF HEALTH & HUMAN SERVS., MONITORING THE FUTURE NAT'L RESULTS ON
ADOLESCENT DRUG USE: OVERVIEW OF KEY FINDINGS 3 (2001)).
37. Id.
38. Id.
39. Controlled Substances Act, 21 U.S.C. §§ 801-971 (1996). Temporary Place-
ment of 3, 4-Methylenedioxymethamphetamine (MDMA) Into Schedule I, 53 Fed.
Reg. 40061-01 (Oct. 13, 1988). Schedules of Controlled Substances; Scheduling of 3, 4-
Methylenedioxymethamphetamine (MDMA) Into Schedule I of the Controlled Sub-
stances Act, 51 Fed. Reg. 36552-01 (Oct. 14, 1986) [hereinafter Final Scheduling
Rule].
40. U.S. SENTENCING COMM'N, REPORT TO THE CONGRESS: MDMA DRUG OF-
FENSES: EXPLANATION OF RECENT GUIDELINE AMENDMENTS 6 (2001) (effecting
amendment of the Federal Sentencing Guidelines to allow for increased penalties for
the possession, manufacture, and trafficking of Ecstasy). In the past ten to fifteen
years, Ecstasy has been either explicitly scheduled (categorized in the penal code) in
all fifty states, or charged under the states' confrolled substance analogue provisions.
See The Alchemind Society, The Drug Law Library: MDMA Law & Policy, at http://
www.alchemind.org/DLL/mdmaindex.htm (last visited Apr. 24, 2002). A controlled
substance analogue is a substance intended for human consumption that is substan-
tially similar to or is represented as being similar to a Schedule I or Schedule II sub-
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stasy's effects varies greatly; some people believe that Ecstasy is a
"safe" drug, unlike heroine or cocaine,4 while others claim that
Ecstasy causes brain damage.42 Driven by fear of health and social
consequences, and not believing that other viable solutions exist,
lawmakers have attempted to stem Ecstasy use by enacting stricter
legal penalties.43
The legal quandary is compounded by scientific confusion. Little
is actually known about the long-term physical and mental effects
of Ecstasy use.44 Administrative barriers and skepticism about use
on human subjects has, until recently, thwarted attempts to con-
duct private research on humans. 45 Government-sanctioned re-
search on the effects of Ecstasy has been challenged as being
neither credible nor thorough.46 The lack of a neutral, reliable, and
comprehensive understanding of Ecstasy's effects has not only af-
fected the decisions of lawmakers, but has contributed to distrust
among teenagers of public information campaigns about Ecstasy
and other drugs.47
This lack of conclusive knowledge of Ecstasy's effects and the
increase in use among teenagers has led lawmakers to establish
stance and is not an approved medication in the United States. 21 U.S.C. § 802(32)(a)
(2001).
41. The Alchemind Society, supra note 40, at 1.
42. Id.
43. E.g., The Ecstasy Anti-Proliferation Act of 2000, Pub. L. No. 106-310, 114 Stat.
1101 (codified as part of the Children's Health Act of 2000, 42 U.S.C. § 290aa-5b
(2000)) (explaining in its findings that stricter penalties are needed to counter the
growing use and trafficking of Ecstasy).
44. Charles S. Grob, Deconstructing Ecstasy: The Politics of MDMA Research, 8
ADDICTION RES. 550, 550 (2000) (discussing the lack of conclusive scientific research
on the effects of Ecstasy use).
45. Id. at 560. In November 2001, the University of California earned FDA ap-
proval to conduct a study wherein twelve people would be given Ecstasy during ther-
apy for posttraumatic stress disorder while eight other people would be given a
placebo. Christopher Newton, FDA Approves Clinical Test, ASSOCIATED PRESS, Nov.
6, 2001, at 2001 WL 29791505. Each person will also undergo sixteen hours of therapy
without drugs. Id. This is the first human study of Ecstasy's use as a potential aid in
treating posttraumatic stress disorder since the drug was made illegal in 1985. Id.
46. U.S. SENTENCING COMM'N, supra note 40, at 8 n.15 (stating that studies done
by George Ricuarte, M.D., one of the biggest contributors to government research on
Ecstasy, have been severely criticized by professionals).
47. Rosenbaum, supra note 36, at Bl ("This generation of DARE [Drug Abuse
Resistance Education] graduates has heard such warnings about a variety of drugs,
including Ecstasy, since they were in grade school. Because the messages are inconsis-
tent with their observations and experiences, they feel duped and simply tune them
out.").
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stricter criminal penalties for Ecstasy use.48 Their hope is that in-
creasing penalties will "send the message" that Ecstasy should be
avoided.49 Harm reduction advocates argue that knowledge of a
drug's effects should precede the establishment of criminal sanc-
tions, and that research which could yield this knowledge should
not be prevented by these laws. 50 Harm reduction advocates also
promote methods of preventing many of Ecstasy's known immedi-
ate side effects like dehydration and overheating, and want to edu-
cate users about ways to reduce the risks of their Ecstasy use.51
Ecstasy provides a clear example of both the ineffectiveness of
the punitive approach to drug policy and the need for mainstream
implementation of harm reduction methods. No other drug has in-
cited so much commentary from scientific and medical communi-
ties,52 and its prevalence among youth is rising rapidly. By
examining the traditionally discordant approaches to drug policy
and their specific application to Ecstasy, a new policy can be
crafted that encompasses the best elements of each approach.
Part I of this Comment discusses the history and development of
harm reduction and the punitive approach: the two main ideologies
on which drug policies are based. It then explains Ecstasy's evolu-
tion as a popular recreational drug, its scientific and medical ef-
fects, and the legislation that has been drafted specifically in
response to its growing popularity in the United States. Part II of
this Comment contrasts various policy approaches to Ecstasy, ex-
ploring the advantages and disadvantages of each. Part III argues
that Ecstasy policy should be revamped to reflect a primarily harm
reduction approach. The first and most radical aspect of this new
policy would involve legalizing Ecstasy with strict government reg-
ulation. In the alternative, Ecstasy should be reclassified as a
48. See, e.g., The Ecstasy Anti-Proliferation Act of 2000, Pub. L. No. 106-310, 114
Stat. 1101 (codified as part of the Children's Health Act of 2000, 42 U.S.C. § 290aa-5b
(2000)); The Ecstasy Prevention Act of 2001, S. 1208, 107th Cong. (2001).
49. E.g., Governor Signs DiGaetano Law Mandating Tougher Sentences for Ec-
stasy Drug, DIGAETANO ON THE ISSUES, at http://pauldigaetano2001.com/issues.htm
(last visited Apr. 17, 2002) (discussing how a new law in New Jersey increasing
sentences for Ecstasy "sends a message to New Jersey's young people as well: stay
away from Ecstasy.").
50. Grob, supra note 44, at 580-81 (discussing the barriers to Ecstasy research).
51. Marsha Rosenbaum, 'Just Say No' Wins Few Points With Ravers, L.A. TIMES,
Jan. 31, 2001, at B9 (explaining, from a parent's perspective, the desire to minimize
the harms that can befall teenage Ecstasy users).
52. U.S. SENTENCING COMM'N, supra note 40, at 4 (stating that the volume of
public comment received on the proposed changes to guidelines for Ecstasy traffick-
ing far exceeds that for any other issue the United States Sentencing Commission has
addressed since its inception).
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I
schedule III substance and the Federal Sentencing Guidelines
should be amended to repeal recent sentence increases for Ecstasy
trafficking. Concurrent with reforming penalty-oriented legisla-
tion, Congress should, as its first priority, increase harm reducing
measures such as treatment, education, and "safer-use" programs
for current users.
I. PROHIBITION, HARM REDUCTION, AND ECSTASY: A
HISTORICAL OVERVIEW
A. Prohibition
The United States prohibitionist policy on drug use is rooted in
the racial prejudice of the late nineteenth century.53 Prohibition
involves the use of law enforcement and strict penalties to deter
and completely eliminate illicit drug use.54 Although the failings of
alcohol prohibition were recognized in the years preceding its re-
peal, the prohibition, as opposed to regulation, of drug use has re-
mained a cornerstone of United States drug policy. 5
1. Early Legislation
In 1914, Congress enacted the Harrison Narcotics Act, a piece of
legislation designed to limit the distribution of cocaine and heroin
to health care professionals, as Opposed to the free use that had
been in effect prior to the statute. 6 In 1919, however, the Supreme
Court interpreted the Harrison Narcotics Act as prohibiting any
distribution of these drugs and held that such distribution was
criminal.5 7 Congress then enacted more than fifty pieces of legisla-
tion controlling the distribution of drugs that were considered dan-
gerous. 58 By the 1960s, penalties in the United States were
generally not related to a drug's inherent danger.59 The govern-
53. GREY, supra note 1, at 20-23.
54. Id. at 20.
55. Dana Graham, Comment, Decriminalization of Marijuana: An Analysis of the
Laws in the United States and the Netherlands and Suggestions for Reform, 23 Loy.
L.A. INT'L & CoMP. L. REV. 297, 301 (2001).
56. Harrison Narcotics Act, Pub. L. No. 63-223, 38 Stat. 785 (1914) (superseded by
§ 2567 of the Internal Revenue Code of 1939, 53 Stat. 278). Lisa Scott, The Pleasure
Principle: A Critical Examination of Federal Scheduling of Controlled Substances, 29
Sw. U. L. REV. 447, 451 (2000) (describing the effect of the Harrison Narcotics Act).
57. Webb v. United States, 249 U.S. 96, 99-100 (1919).
58. H.R. REP. No. 91-1444 (1970), reprinted in 1971 U.S.C.C.A.N. 4566, 4601
("Since 1914 the Congress has enacted more than fifty pieces of legislation relating to
control and diversion, from legitimate channels, of those drugs referred to as narcotics
and dangerous drugs.").
59. DAVID F. MUSTO, THE AMERICAN DISEASE 255 (1999).
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ment sought to correct this imbalance by establishing a reliable
process for determining the level of danger posed by any given
drug.6 ° Congress enacted the Comprehensive Drug Abuse and
Prevention Control Act of 1970, which harmonized all federal drug
laws into one piece of comprehensive legislation. 6 The part of the
Act relevant to this Comment is Title II, now commonly called the
Controlled Substances Act (the "Act"), which focuses on strength-
ening existing law enforcement authority in the field of drug
abuse.6z The Act is the government's legal foundation in its fight
against drug abuse.63
2. The Controlled Substances Act
The Controlled Substances Act authorizes the Attorney General
to establish five categories of controlled substances for the purpose
of regulating their use, possession, and sale.64 The categories are
known as schedules, and they range from I to V, with schedule I
and II substances provoking the strictest controls and most severe
criminal penalties.6 5 Heroin and marijuana are schedule I sub-
stances and cocaine is a schedule II substance.66 The Attorney
General has power to delegate to the Administrator of the Drug
Enforcement Administration ("DEA") the responsibility of plac-
ing drugs in a schedule, which is how scheduling usually occurs.67
Proceedings to add, delete, or change the schedule of a drug may
be initiated by the DEA, the Department of Health and Human
Services ("HHS"), or by petition from any interested party.68
Once a petition is received by the DEA, the agency begins its own
investigation of the drug.69 The DEA Administrator then asks
HHS to complete a scientific and medical evaluation and make a
recommendation as to whether the substance should be con-
trolled.70 To accomplish this task, HHS gathers information from
the Food and Drug Administration ("FDA") and the National In-
60. Id. at 254-55.
61. Controlled Substances Act, Pub. L. No. 91-513, 84 Stat. 1236 (1970) (codified
as part of 21 U.S.C. §§ 801-971). Scott, supra note 56, at 451.
62. Controlled Substances Act, 21 U.S.C. §§ 801-971 (1996).
63. Id. at 455.
64. Controlled Substances Act, 21 U.S.C. §§ 801-971 (1996).
65. Id. § 812.
66. Id.
67. Id. § 811.
68. Drug Enforcement Admin., Summary of Controlled Substances Act, at http://
www.dea.gov/agency/csa.htm (last visited Apr. 25, 2002).
69. Id.
70. Id.
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stitute on Drug Abuse ("NIDA").7" The medical and scientific
evaluations by HHS are binding on the DEA only for substances
HHS urges not be controlled by the DEA.72 Whether HHS has
ever made such a recommendation against the wishes of the DEA
remains unknown, but it is highly unlikely. The Administrator of
the DEA then reviews all available data and decides whether a
drug should be controlled and if so, into which schedule it should
be placed.73 This decision is final and, for all practical purposes, is
not subject to review.74 Judicial review of an agency decision re-
quires a court of appeals to find an extreme level of error; thus,
reversal is unlikely.75
If the DEA Administrator determines that a substance should be
controlled, the decision as to in which schedule a drug will be
placed depends on several factual findings regarding the drug's
abuse potential and medicinal properties. 76 Schedule I drugs re-
quire the following findings:
1. The drug or other substance has a high potential for abuse;
2. The drug or other substance has no currently accepted med-
ical use in treatment; and
3. There is a lack of accepted safety for use of the drug or
other substance under medical supervision.77
For schedule II, the required findings are:
1. The drug or other substance has a high potential for abuse;
2. The drug or other substance has a currently accepted medi-
cal use in treatment in the United States or a currently ac-
cepted medical use with severe restrictions; and
3. Abuse of the drug or other substances may lead to severe
psychological or physical dependence.78
Schedule III requires the following:
71. Id.
72. Id.
73. Id.
74. See Grinspoon v. DEA, 828 F.2d 881, 884-85 (1st Cir. 1987) (discussing the
standard of review for an agency decision and holding that the DEA's standard for
acceptable medical use was not in accordance with the congressional intent of the
Act, but that all other claims were invalid or resulted only in harmless error). The
Administrative Procedure Act directs that the reviewing court shall set aside agency
conclusions found to be arbitrary, capricious, an abuse of discretion, or otherwise not
in accordance with law. 5 U.S.C. § 706(2)(A) (1996).
75. 5 U.S.C. § 706(2)(a); see Grinspoon, 828 F.2d at 884-85.
76. Controlled Substances Act, 21 U.S.C. § 812 (1996).
77. Id.
78. Id.
2144
AGONY OF ECSTASY
1. The drug or other substance has a potential for abuse less
than the drugs or other substances in schedules I and II;
2. The drug or other substance has a currently accepted medi-
cal use in treatment in the United States; and
3. Abuse of the drug or substance may lead to moderate or
low physical dependence or high psychological
dependence.79
The classification of substances depends on fairly nuanced differ-
ences implied by the differing standards of "accepted medical use"
and "potential level of dependence," although the Act itself does
not contain clear criteria by which the DEA Administrator must
measure these properties. In the House Committee Report accom-
panying the Act, lawmakers attempted to provide some guidance
on the "potential for abuse" criterion.8 ° The Report states that the
Attorney General may find a substance has potential for abuse if
individuals are taking the drug in amounts sufficient to create a
hazard to their health, or to the safety of other individuals or of the
community; there is significant diversion of the drug from legiti-
mate drug channels; individuals are taking the drug on their own
initiative rather than on medical advice; or the drug is related to a
drug already listed as having a potential for abuse.8' According to
the third prong, any drug used for recreational purposes has a po-
tential for abuse. Furthermore, there is no clear standard for de-
termining an elevation to a "high" potential for abuse, as required
for schedule I classification.82
The definition of "currently accepted medical use" was a primary
issue in the litigation brought to challenge Ecstasy's placement in
schedule 1.83 This standard was defined by past DEA Administra-
tor John C. Lawn as "having obtained FDA approval. 84 The ben-
efit of this interpretation is that the detailed scientific research
required for FDA approval85 would likely be nuanced enough to
also demonstrate whether a substance has a high potential for
abuse. If, however, "currently accepted medical use" is defined
79. Id.
80. Scott, supra note 56, at 454.
81. H.R. REP. No. 91-1444 (1970), reprinted in 1971 U.S.C.C.A.N. 4566, 4601.
82. 21 U.S.C. §§ 801-971.
83. See Schedules of Controlled Substances; Scheduling of 3, 4-Methylenediox-
ymethamphetamine (MDMA) Into Schedule I of the Controlled Substances Act, 21
C.F.R. § 1308 (1986).
84. Id.
85. See Julie Holland, Clinical Experience with MDMA-Assisted Psychotherapy, an
Interview with George Greer, M.D., in ECSTASY: THE COMPLETE GUIDE, supra note
34, at 240.
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more accurately as "what is actually going on within the health care
community, '8 6 then assessing a substance's abuse potential would
have to depend on other research-research that the DEA neither
mandates nor permits. Neither the DEA nor any judicial body has
presented a means to measure a substance's abuse potential.87 The
DEA Administrator is therefore given significant discretion with-
out judicial review or substantive congressional guidance.88 More-
over, the DEA Administrator faces a conflict of interest: the
Administrator both classifies drugs and promotes a punitive crimi-
nal justice approach to drug abuse. This process may result in sub-
stance classifications that are, if not legally arbitrary and
capricious,8 9 at least lacking in scientific and political merit.
3. The Creation of Sentencing Guidelines and
Subsequent Legislation
In 1973, the National Institute on Drug Abuse ("NIDA") was
established to act as the umbrella organization for most govern-
ment prevention programs and drug research.9° Eleven years later,
the 1984 Federal Sentencing Reform Act established the United
States Sentencing Commission and charged it with creating sen-
tencing guidelines for criminal defendants in federal court. 91 In-
cluded in the sentencing guidelines were mandatory minimum
sentences for drug offenses committed near schools. 92
In the 1980s, public sentiment grew increasingly antidrug, as so-
ciety evaluated the collective damage of drug use in the 1970s and
watched as cocaine grew in popularity.93 In response to the "crack
86. This was the definition found by DEA Administrative Law Judge Francis L.
Young. Final Scheduling Rule, supra note 39.
87. See id.
88. See id.
89. See Motor Vehicle Mfrs. Ass'n of United States, Inc. v. State Farm Mut. Auto
Ins. Co., 463 U.S. 29, 43 (1983) ("Normally, an agency rule would be arbitrary and
capricious if the agency relied on factors which Congress has not intended it to con-
sider, entirely failed to consider an important aspect of the problem, offered an expla-
nation for its decision that runs counter to the evidence before the agency, or was so
implausible that it could not be ascribed to a difference in view or the product of
agency expertise.").
90. MUSTO, supra note 59, at 257.
91. Federal Sentencing Reform Act, Pub. L. No. 98-473, 98 Stat. 1837 (1984)
(codified at 18 U.S.C. 3551); MUSTO, supra note 59, at 273-74.
92. MUSTO, supra note 59, at 274.
93. Drug use among young people was at a near-epidemic level in the late 1970s.
OFFICE OF NAT'L DRUG CONTROL POLICY, NATIONAL DRUG CONTROL BUDGET: Ex-
ECUTIVE SUMMARY, FISCAL YEAR 2002 (2002); Abbie Crites-Leoni, Medicinal Use of
Marijuana: Is the Debate a Smoke Screen for Movement Toward Legalization?, 19 J.
LEGAL MED. 273, 276 (1998) (discussing the antidrug sentiment of the mid-1980s).
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epidemic, 94 Congress enacted the Anti-Drug Abuse Act of 1986.95
It set forth a spectrum of mandatory minimum sentences for crimi-
nal offenses where crack cocaine was found in a defendant's pos-
session.96 Two years later, the Anti-Drug Abuse Act of 1988 was
enacted.97 Under this statute, alcohol was included with other
drugs, and states were encouraged to adopt heightened penalties
for drunk driving in exchange for grant money.98 Later that year,
this act was amended to include The Drug-Free Schools and Com-
munities Act Amendments of 1986. 9 Educational institutions
were required to establish a means of maintaining drug-free cam-
puses, informing students and employees at the beginning of each
school year of the penalties for drug use or sale, and providing in-
formation on available treatment.100
In addition to implementing legislation generally addressing
drug abuse, Congress has taken new measures to stem Ecstasy use
and trafficking. Two bills specifically addressing Ecstasy and other
club drugs'0 1 have been introduced in the past three years: the Ec-
stasy Anti-Proliferation Act of 2000 and the Ecstasy Prevention
Act of 2001.1°2 The DEA has also unsuccessfully attempted to use
legislation commonly known as the "crack house" statutes 10 3 to
94. Crack is a smokable, rapidly reacting form of cocaine base. Soon after crack
first appeared, in the early to mid-1980s, crack abuse swept through the country.
Philip B. Heyman, The New Policing, 28 FORDHAM URB. L.J. 407, 409 (2000).
95. Anti Drug Abuse Act of 1986, Pub. L. No. 99-570, 100 Stat. 3207 (codified at
21 U.S.C. 801 (1999)).
96. Id.; MUSTO, supra note 59, at 274. The Anti-Drug Abuse Act of 1986 estab-
lished mandatory minimums for persons convicted of trafficking controlled sub-
stances, and it established a 100-to-1 quantity ratio between crack and powder
cocaine. Id. That means that it takes 100 times as much powder cocaine to trigger the
same mandatory penalties as for a given amount of crack. Id. In 1987, the United
States Sentencing Commission used the same ratio to set penalties under the Sentenc-
ing Guidelines. U.S. SENTENCING COMM'N, SPECIAL REPORT TO THE CONGRESS: CO-
CAINE AND FEDERAL SENTENCING POLICY iv (1995).
97. Anti-Drug Abuse Act of 1986, Pub. L. No. 99-570, 100 Stat. 3207 (codified as
21 U.S.C. 801 (1999)).
98. Id. at Title I, Subchapter T.
99. Drug-Free Schools and Communities Act of 1986, Pub. L. No. 100-297, 102
Stat. 252 (codified as part of 20 U.S.C. 3171 (1994)).
100. Id.
101. Club drugs are those typically used by young adults at bars, clubs, and raves,
including Ecstasy, GHB, Rohypnol, Ketamine, Methamphetamine, and LSD. Nat'l
Inst. on Drug Abuse, Club Drugs, at http://www.clubdrugs.org (last visited Apr. 23,
2002).
102. The Ecstasy Anti-Proliferation Act of 2000, Pub. L. No. 106-310, 114 Stat. 1101
(codified as part of the Children's Health Act of 2000, 42 U.S.C. § 200aa-5b (2000));
The Ecstasy Prevention Act of 2001, S. 1208, 107th Cong. (2001).
103. 21 U.S.C. § 856(a)(2) (2000). The statute declares it unlawful to knowingly
open or maintain any place for the purpose of manufacturing, distributing, or using
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prosecute club owners and rave 10 4 promoters in federal courts. 10 5
In United States v. Barbecue of New Orleans,"°6 the DEA and club
owners charged under the "crack house" statutes reached a settle-
ment wherein the DEA required the club owners to ban rave cul-
ture accoutrements such as glow sticks and pacifiers. 7 However,
New Orleans Federal District Judge Thomas Porteous permanently
enjoined such a ban, finding that the government cannot ban inher-
ently legal objects that are used in expressive communication sim-
ply because they may also be used to enhance the effects of an
illegal substance.10 8 He further held that "[W]hen [a] First Amend-
ment right ... is violated by the government in the name of the
War on Drugs ... it is the duty of the courts to enjoin the govern-
ment from violating the rights of innocent people."'0 9
B. Harm Reduction
Harm reduction" rests on two premises: first, that psychoactive
drug use has been a part of every culture since the beginning of
any controlled substance or to manage or control any building, room, or enclosure,
either as an owner, lessee, agent, employee, or mortgagee, and knowingly and inten-
tionally rent, lease, or make available for use, with or without compensation, the
building, room, or enclosure for the purpose of unlawfully manufacturing, storing,
distributing, or using a controlled substance. Id.
104. Raves are large, incandescent dance parties where electronic music is played.
Gwen Filosa, Sponsor's Guilty Plea Brings Rave New World, TIMES-PICAYUNE, Jun.
14, 2001, at 1.
105. Federal Judge Throws Out Glow Stick, Pacifier Ban in New Orleans Rave Case,
THE WEEK ONLINE WITH DCRNET, Feb. 8, 2002, at http://www.drcnet.org/wol/
223.html (last visited Apr. 23, 2002) [hereinafter Pacifier Ban]. The DEA attempted
to stretch the meaning of the "crack house" statutes to allow for the prosecution of
anyone who operates a business where drug use occurs, and where the building man-
agement are aware of the drug use; United States v. Brunet, No. 01-010 (E.D. La.
Mar. 7, 2001).
106. United States v. Barbecue of New Orleans, Inc., No. 01-153 (E.D. La. Aug. 23,
2001).
107. Pacifier Ban, supra note 105. Pacifiers and light sticks are sometimes used at
raves or large clubs by people using Ecstasy and other club drugs to enhance the
effects of the drugs. Stacy St. Clair, Why Image Could Doom Teen Club, CHI. DAILY
HERALD, May 2, 2002, at Al.
108. McClure v. Ashcroft, No, 01-2573 (E.D. La. Feb. 1, 2002).
109. Id.
110. Harm reduction is a term of art intended to encompass a spectrum of ap-
proaches to drug use. Inciardi & Harrison, supra note 31, at vii-viii. The more tradi-
tional understanding of the ideology allows a person to use drugs, even to the point of
causing harm to herself, without interference from the government. Id. A more recent
understanding of harm reduction includes the goal of reducing drug use. Id. (describ-
ing one theory of harm reduction that supports prohibition but seeks to minimize its
negative effects). For the purpose of this Comment, harm reduction is a hybrid of
these approaches: it is a method to minimize drug related harm and the harm caused
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civilization, rendering eradication unrealistic and probably impossi-
ble, and second, that drug use is primarily a social and public
health issue as opposed to a penal issue.111 In practice, harm re-
duction encompasses programs that attempt to make drug use as
safe as possible for both the users and the community. 1 2 Examples
of specific programs include syringe exchanges for intravenous
drug users; treatment programs; "safer-use" educational campaigns
that offer objective, factual information to drug users; and treat-
ment as an alternative to incarceration for convicted drug offend-
ers.1 13 Harm reduction advocates recognize that drug use can
never be completely safe, and some acknowledge the need for law
enforcement in certain circumstances."14
Harm reduction is often confused with legalization. Legalization
involves removing criminal penalties for possession of some or all
illicit drugs and usually involves implementing a system of regu-
lated distribution similar to that which is in place for alcohol and
cigarettes, with state-run sales, quality and price control, and a ban
on advertising." 5 Legalization advocates often point to crime
caused by prohibitive drug laws themselves as support for legaliza-
tion." 6 Although many harm reduction advocates support legali-
by the punitive criminal justice approach. Although this Comment includes preven-
tion and treatment measures under the umbrella of harm reduction, the traditional
harm reductionist would advocate only treatment, and only for voluntary and willing
participants. See Harm Reduction Coalition, Harm Reduction Principles, at http://
www.harmreduction.org/prince.html (last visited Apr. 23, 2002) (stating that drug
treatment should be noncoercive).
111. See Nadelmann & Wenner, supra note 32, at 24-26 (elaborating on the role
that drug use has played in societies through history); Inciardi & Harrison, supra note
31, at vii-viii (describing one definition of harm reduction as accepting the reality of
drug use and the harms caused by such use while preserving the choice of individuals
to engage in drug use or to forego drug use); Telephone Interview with Ethan
Nadelmann, Director, Drug Policy Alliance (Feb. 13, 2002).
112. See JEROME BECK & MARSHA ROSENBAUM, PURSUIT OF ECSTASY: THE
MDMA EXPERIENCE 136 (1994); Inciardi & Harrison, supra note 31, at vii. This un-
derstanding of harm reduction has also been referred to as "Safety First." Telephone
interview with Marsha Rosenbaum, West Coast Director, Drug Policy Alliance (Nov.
12, 2001).
113. See Robert J. MacCoun, Toward a Psychology of Harm Reduction, 53 AM.
PSYCH. 1199, 1199-1208 (1998) (discussing the many programs that can fall into the
category of harm reduction).
114. See id. (proposing a policy incorporating harm reduction and law
enforcement).
115. See GRAY, supra note 1, at 213-14 (discussing regulated distribution and legali-
zation generally).
116. See WILLIAM WEIR, IN THE SHADOW OF THE DOPE FIEND: AMERICA'S WAR
ON DRUGS 253 (1995) (stating that twenty to forty percent of the murders in America
take place because of the black market drug business); David R. Henderson, A Hu-
mane Economist's Case for Drug Legalization, 24 U. CAL. DAVIS L. REV. 655, 659
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zation to some extent, legalization is a broader approach to drug
policy that is not necessarily informed by the social and medical
concerns underlying harm reduction.'1 7 In fact, most legalization
arguments are economic.' 8
Decriminalization may be a component of harm reduction, but it
is a distinct approach advocating that selected laws not be enforced
and that penalties for possession be substantially reduced." 9 In
practice, decriminalization directs law enforcement efforts away
from minor possession of less harmful drugs and toward larger dis-
tribution networks involving more dangerous drugs. 120 By altering
the manner in which criminal drug laws are enforced, decriminal-
ization aims to reduce harms to drug users arising from the crimi-
nal justice system itself, while more efficiently utilizing government
resources.' 2' Examining the development of harm reduction in the
Netherlands and its subsequent migration to the United Kingdom
and North America enables a complete understanding of this ap-
proach and its various applications.122
(1991) (discussing the phenomenon of drug users committing other crimes to afford
drugs, which are made more expensive because of prohibitive laws).
117. Although legalization is generally proposed for its efficiency, it would proba-
bly not result in increased drug use. Using cigarettes as a model, even if self-reports
of alcohol and tobacco consumption underreport actual consumption by as much as
thirty to fifty percent, at least seventy percent of Americans are resistant to the temp-
tations and risks posed by the easy availability of cigarettes. Further, more than
ninety percent of the population either refrains from powerful drugs altogether or
else consumes them responsibly and in moderation. Nadelmann, supra note 14.
118. Joshua C. LaGrange, Note, Law, Economics, and Drugs: Problems with Legal-
ization Under a Federal System, 100 COLUM. L. REV. 505, 505 (2000) ("Proponents of
drug legalization often find support for their position in neo- classical economic theo-
ries that demonstrate the inefficiency of supply- restricting drug control policies like
those traditionally used in the United States.").
119. GRAY, supra note 1, at 7; Hearing Before the House Gov't Reform and Over-
sight Comm., Subcomm. on Criminal Justice, Drug Policy, and Human Res., 106th
Cong. 1 (1999) (statement of Robert J. MacCoun & Peter Reuter). For the purpose
of this Comment, discussion of harm reduction will not include decriminalization ex-
cept where explicitly mentioned as part of a multi-faceted approach to drug policy.
120. See Graham, supra note 55, at 320 (explaining the predominant argument for
decriminalization of marijuana as removing penalties for personal use by adults while
arresting commercial sellers).
121. See Stephen B. Duke, Drug Prohibition: An Unnatural Disaster, 27 CONN. L.
REV. 571, 611 (1995) (discussing the reallocation of government resources that could
take place if some drugs were decriminalized). See generally SAM STALEY, DRUG POL-
ICY AND THE DECLINE OF AMERICAN CITIES (1992) (arguing that decriminalization is
an important step toward addressing the economic and social needs of cities).
122. See Diane Riley & Pat O'Hare, Harm Reduction: History, Definition, and
Practice, in HARM REDUCTION: NATIONAL AND INTERNATIONAL PERSPECTIVES,
supra note 19, at 3 (stating that harm reduction developed in the Netherlands, the
United Kingdom, and North America).
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1. The Netherlands
The Dutch established a drug policy guided by harm reduction
ideology with the development of three innovative concepts. 12
3
The first concept is that different drugs carry different risks, some
acceptable and some not.124 This concept was developed as a re-
sponse to the increase in drug use in the 1960s.1 2 5 This increase led
to broad public concern about the operation of the criminal justice
system. 26 Specific concerns about the effect of drug laws on per-
sonal choice, the consequences of criminalization, and the risks to
the user, led the Dutch government to create an official commis-
sion (the "Commission") to study the increased use of narcotics
and issue a report proposing possible solutions.127 The Commis-
sion's thorough report proposed that the bases for all future drug
policy be "risk-criteria," principles for legislation and policy-mak-
ing that would take into account the relative risks of illegal
drugs. 121 In 1972, the emergence and rapid spread of heroin put
pressure on the government to seriously discuss the Commission's
report and consider legal reforms.1 29 Applying risk criteria, legisla-
tors decided that the law should distinguish between "drugs
presenting unacceptable risks," such as heroin, cocaine, LSD, and
amphetamines, and drugs presenting acceptable risks, such as hash-
ish and marijuana. 3 ° This concept, that "hard" and "soft" drugs
should be separated both legally and in the public's perception, is
one of the most significant and effective elements of Dutch harm
reduction. 131 In 1976, the Dutch codified this policy by creating
two classes of drugs, schedule I and schedule II, which reflect the
respective risks of the drugs. 2
Prevention, treatment, and risk minimization comprise the sec-
ond aspect of Dutch harm reduction.1 33 By preventing nonusers
123. BECK & ROSENBAUM, supra note 112, at 136.
124. Henk Jan van Viiet, The Uneasy Decriminalization: A Perspective on Dutch
Drug Policy, 18 HOFSTRA L. REV. 717, 720 (1990).
125. Id.
126. Id. at 720-21.
127. See id. at 722 (describing the creation, goals, and function of the Commission,
officially called the Baan Working Party).
128. Id. at 722.
129. Id. at 723.
130. Id. at 724.
131. See Dirk K. Korf & Ernst C. Buning, Coffee Shops, Low-Threshold Metha-
done, and Needle Exchange: Controlling Illicit Drug Use in the Netherlands, in HARM
REDUCTION: NATIONAL AND INTERNATIONAL PERSPECTIVES, supra note 19, at 116.
132. Id. at 118.
133. van Vliet, supra note 124, at 725.
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from trying "hard" drugs and helping current users abstain, the
Dutch believed they could reduce risks both to drug users and soci-
ety.134 Professionals in the field soon realized that abstinence-only
methods were inadequate; relying solely on treatment and preven-
tion left the majority of drug users, who were not seeking absti-
nence, without a range of necessary services. 135 These profes-
sionals began providing medical and social assistance to injection
drug users who were not seeking abstinence, allowing them to
monitor and influence the health, social, and legal status of the
users while reducing damage to society.136
The third and most widely known element of Dutch drug policy
is decriminalization. Decriminalization is based on the "normaliza-
tion" '137 or "cultural integration" 138 that the state reaches when the
public believes the eradication of drugs is unattainable. 139 The
Dutch enacted a policy of pragmatic nonenforcement for violations
involving the sale or possession of up to approximately one-fifth of
an ounce of marijuana. 14 Marijuana's decriminalization keeps
transactions public to prevent a health issue from becoming a
crime problem. 141
2. The United Kingdom
The United Kingdom instituted a program of regulated distribu-
tion of certain drugs for addiction maintenance in the 1980s, and
instituted other harm reduction tactics derived from the Dutch ap-
proach. 142 In response to epidemic levels of heroin use, the city of
134. Id. at 725.
135. Id. at 725 n.40.
136. Id. at 726.
137. van Vliet, supra note 124, at 727; see Rodney Skager, Education, Prevention,
and Treatment, 28 FORDHAM URn. L.J. 130, 131 (2000) (explaining normalization as
what occurs when users, as well as many nonusers, accept some amount of drug use as
normal).
138. van Vliet, supra note 124, at 727.
139. Id. at 726-27.
140. GRAY, supra note 1, at 217-18 (noting that the amount of marijuana allowed
under this policy was reduced from one ounce to one-fifth of one ounce in 1995 be-
cause of political pressure); TIM BOEKHOUT VAN SOLINGE, DRUGS AND DECISION-
MAKING IN THE EUROPEAN UNION 124 (2002) (stating that the Dutch amended their
marijuana policy in response to pressure from its European Union neighbors).
141. GRAY, supra note 1, at 218.
142. Inciardi & Harrison, supra note 31, at ix (detailing the beginning of the United
Kingdom's first comprehensive harm reduction program); Norbert Gilmore, Drug
Use and Human Rights: Privacy, Vulnerability, Disability, and Human Rights Infringe-
ments, 12 J. CONTEMP. HEALTH L. & POL'Y 355, 405 (1996), available at http://
www.drugtext.org (last visited Apr. 22, 2002) (stating that the United Kingdom has
steadily favored a regulatory approach to control drug use, which has resulted in the
2152
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Merseyside, England adopted a harm reduction program known as
the "Mersey model.' 1 43 This program served three separate func-
tions. The first component of the Mersey model, maintenance, was
instituted after a committee concluded that maintenance on drugs
is necessary for some drug-addicted persons to lead useful lives.'"
The second element was the creation of one of the first syringe
exchange programs in the United Kingdom. 145 The third compo-
nent was informal decriminalization. In lieu of arrest, local police
began to refer drug users to drug services, a practice known as
"cautioning. ' 146 The Mersey model grew to include counseling,
prescription of drugs (including heroin), and employment and
housing services. a14
United Kingdom drug policy has evolved significantly over time.
In 1971, Britain's drug policy became primarily prohibition-
based, 48 with the Mersey model developing as an exception; some
of those harm reduction tactics continue to be applied in certain
areas. 49 International treaty obligations have kept British drug
policy grounded mainly in the punitive-based criminal justice ap-
proach.15 0 A number of British lawmakers and law enforcement
leaders have recently expressed disfavor with this prohibitionist
medical availability of heroin and methadone, an emphasis on medical, rather than
criminal justice, definitions of harmful use, and the implementation of innovative
harm reduction approaches).
143. Riley & O'Hare, supra note 122, at 4.
144. Id.
145. Id. This was called the Mersey Regional Drug Training and Information Cen-
tre. Id.
146. Id.
147. Id.
148. In 1971 the United Kingdom enacted the Misuse of Drugs Act, a piece of
legislation based on the prohibitionist approach to drug policy. VISCOUNTESS RUNCI-
MAN DBE, DRUGS & THE LAW: REPORT OF THE INDEPENDENT INQUIRY INTO THE
MISUSE IF DRUGS AcT 1971 1 (1999).
149. Riley, supra note 122, at 4 (listing elements of the Mersey model); Harold
Seymour & Gail Eaton, The Liverpool Model: A Population Based Approach to Harm
Reduction, March 1997, at http://www.drugtext.org/articles/97844.htm (last visited
Apr. 25, 2002) (discussing the elements of the Mersey Model that were still in use in
1997).
150. See, e.g., GRAY, supra note 1, at 147 (discussing the creation of the United
Nation's International Narcotics Drug Control Board which, in 1997, issued a report
that essentially called for criminalizing any opposition to the war on drugs); United
Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Sub-
stances, U.N. ESCOR, U.N. Doc. E/CONF 82/15 (1988), reprinted in 28 I.L.M. 493;
United Nations Convention on Psychotropic Substances, Feb. 21, 1971, 1019 U.N.T.S.
175, reprinted in 10 I.L.M. 261.
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scheme.151 A member of the Liberal Democratic Party recently
stated, "The current position is one that is completely out of con-
trol. The status quo is no longer an option. ' 152 The Association of
Chief Police Officers, a group comprised of the country's police
chiefs, called for the free, regulated, and legal distribution of her-
oin to addicts because it believed that the current approach was not
working.153 As Chief Constable Barry Straw observed, "If there is
indeed a war on drugs, it is not being won; drugs are demonstrably
cheaper and more readily available than ever before.' 1 54 In March
2002, the British Government announced a plan to ignore personal
use of Ecstasy and other club drugs while focusing enforcement
efforts on dealers and the impact of "hard drugs" such as heroin
and cocaine. 155 In a new set of Home Office guidelines, the Gov-
ernment demonstrates its acceptance that drug-taking is a part of
youth culture that cannot be eradicated.156 The guidelines "give
clubs advice on how to prevent dealing and how to make the ve-
nues safer for drug-using club goers," including the provision of
water and better ventilation. 5 7
3. The United States
Harm reduction methods in the United States have traditionally
been proposed and implemented only by public health profession-
als or grass roots organizations.' 58 While the United States has not
utilized many of the harm reduction practices that originated in the
Netherlands and the United Kingdom, it has fostered one signifi-
cant harm reduction strategy, methadone maintenance. 59 Imple-
151. Top British Cops Call for Legal Heroin for Addicts, Liberal Democrats Join
Growing Ecstasy Rescheduling Chorus, THE WEEK ONLINE WITH DRCNET, Dec. 14,
2001, at http://www.drcnet.org/wol/215.html (last visited Apr. 25, 2002) (statement of
Baroness Walmsley, head of the Liberal Democratic Party panel that produced a re-
port calling for the downward classification of both cannabis and Ecstasy).
152. Id.
153. Id.
154. Id. See generally Gerber, supra note 23 (discussing the ineffectiveness of the
current drug policy).
155. Richard Ford, Dance Clubs Given a License to Go Soft on Drugs, TIMES OF
LONDON, Mar. 8, 2002, at 3.
156. Id.
157. Id.
158. See Riley & O'Hare, supra note 122, at 11 (discussing the United States' resis-
tance to the harm reduction practice of needle exchange and the endorsement of the
program by two national AIDS commissions and the National Academy of Science).
159. Id. at 5. Methadone maintenance is the administration of methadone, a syn-
thetic opiate, to a heroin addict to take away the addict's craving for heroin. GRAY,
supra note 1, at 195.
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mented in Canada in the late 1950s and in the United States in the
early 1960s, methadone maintenance was seen as a way to reduce
the societal harm resulting from crimes related to heroin addic-
tion.160 In the past forty years, methadone maintenance programs
have gained increased political and scientific support in the United
States.16' The Office of National Drug Control Policy has ex-
pressed support for such programs,162 and a 2000 study conducted
by the National Institute on Drug Abuse ("NIDA") found that
"methadone maintenance is an effective treatment for heroin
addiction.'1 63
While United States drug policy has remained entrenched in the
criminal justice model, 64 some aspects of harm reduction in its
broadest meaning have seeped into the criminal justice system.
Two notable programs comingle treatment with law enforcement,
Treatment Alternatives to Street Crime and the Therapeutic
Community.
Treatment Alternatives to Street Crime ("TASC") is a private
business operating in more than 100 jurisdictions in the United
States, and acting as a bridge between the criminal justice system
and drug treatment communities. 65 Once contracted, TASC iden-
tifies, assesses, and refers drug-involved offenders to community
treatment services as an alternative or supplement to existing crim-
inal sanctions. 66 After making the referral, TASC monitors the
offender's progress and compliance and reports back to the refer-
ring justice system agency.' 67 Offenders who violate any of the
conditions of participation with TASC are sent back to the criminal
160. Riley & O'Hare, supra note 122, at 5.
161. Edward Jurith, Is Our Drug Policy Effective?, 28 FORDHAM URn. L.J. 4, 44
(2000) ("The federal government is also undertaking a review of the methadone
maintenance program. Our aim is to have methadone programs and methadone
treatment outcomes accredited by health care standards, and not just by regulatory
standards, as has been done in the past."); Press Release, NIDA, New Study Under-
scores Effectiveness of Methadone Maintenance as Treatment for Heroin Addiction
(Mar. 7, 2000) (on file with author).
162. Jurith, supra note 161, at 44.
163. NIDA NEws RELEASE, supra note 161.
164. Kal Raustiala, Law, Liberalization, & International Narcotics Trafficking, 32
N.Y.U. J. INT'L L. & POL. 89, 137 (1999) (discussing the focus of U.S. drug policy on
criminal justice).
165. James A. Inciardi, The Harm Reduction Roles of the American Criminal Justice
System, in HARM REDUCTION: NATIONAL AND INTERNATIONAL PERSPECTIVES, supra
note 19, at 199.
166. Id.
167. Id. at 200.
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justice system. 168 Some data suggests that TASC-referred clients
remain in treatment longer than non-TASC clients and that they
have better post-treatment success.1 69
Therapeutic Communities ("TCs") are used increasingly in cor-
rectional facilities, where the facility isolates a community from the
rest of the prison population to separate them from the drugs, vio-
lence, and prison subculture that could interfere with rehabilita-
tion.170 The overall goal of a TC is to change a person's patterns of
behavior and thinking to foster a responsible, drug-free lifestyle. 7 '
In the late 1990s, studies documented the effectiveness of treat-
ment programs designed for drug-involved offenders and resulted
in the allocation of more federal funds to corrections-based
treatment.172
Several nonprofit organizations promoting harm reduction have
also developed in the past few years. 173 They often focus on dis-
seminating "safer-use" information to people who choose to use
drugs in spite of the known risks.174 In 1999, a nonprofit organiza-
tion called DanceSafe was founded to provide harm reduction ser-
vices to the growing club and rave populations.'75 One of
DanceSafe's primary functions is providing adulterant testing 176 of
168. Id.
169. Id.
170. Id. Programs such as TCs indicate recognition by lawmakers and prison offi-
cials that the drug culture pervades American prisons despite their failure to openly
acknowledge this fact or refer to TCs as a form of harm reduction.
171. Id.
172. Id. at 201; see, e.g., M. DOUGLAS ANGLIN, ET. AL., STUDIES OF THE FUNCTION-
ING AND EFFECTIVENESS OF TREATMENT ALTERNATIVES TO STREET CRIME (TASC)
PROGRAMS (1996); James A. Inciardi et. al., An Effective Model of Prison-Based
Treatment for Drug-Involved Offenders, 27 J. DRUG ISSUES 261 (1997); SANDRA TU-
NIS ET. AL., EVALUATION OF DRUG TREATMENT IN LOCAL CORRECTIONS, (1996).
173. See, e.g., DanceSafe, at http://www.dancesafe.org (last visited Apr. 16, 2002);
Harm Reduction Coalition, at http://www.harmreduction.org (last visited Apr. 16,
2002); The Lindesmith Center, at http://www.drugpolicy.org (last visited Apr. 16,
2002).
174. See, e.g., Diane Riley, Canadian Centre on Substance Abuse, The Harm Re-
duction Model: Pragmatic Approaches to Drug Use from the Area Between Intolerance
and Neglect (1993) (claiming that research has shown that users will change their be-
havior in response to information about safer use); Harm Reduction Coalition, Princi-
ples of Harm Reduction, at http://www.harmreduction.org/prince.html (last visited
Apr. 16, 2002) (discussing the need for accurate information about drugs and drug
use, including their adverse and harmful effects).
175. See DanceSafe, supra note 173.
176. Adulterant testing or pill testing is conducted in one of three ways: onsite at
clubs and raves, in a lab, or with testing kits that can be ordered from DanceSafe. Id.
Through the onsite program, users who are unsure of the authenticity of a pill they
possess can bring it to a booth where trained harm reduction volunteers will test it for
adulterants using a reliable, liquid reagent. Id.
AGONY OF ECSTASY
pills sold in clubs as Ecstasy.177 In this capacity, DanceSafe either
distributes test kits through the mail, tests pills in a California lab
sanctioned by the DEA for this purpose, or provides on-site testing
to determine if a pill contains substances other than Ecstasy. 178 In
an on-site testing situation, if an adulterant is found, the DanceSafe
tester provides the user with information about the specific risks of
the actual substances in the pill.179 DanceSafe's target audience is
comprised primarily of nonaddicted, recreational drug users who
realize there are risks involved in drug experimentation, but often
are not aware of all of the risks.180
Prevention education has long been considered an integral part
of a comprehensive drug policy, but how to use it most effectively
is a subject of great debate. 181 The national prevention program,
Drug Abuse Resistance Education ("DARE"), advocates absti-
nence and is taught in eighty percent of the nation's school dis-
tricts.1 82 However, extensive research during the past two decades
has identified a number of other prevention strategies that measur-
ably reduce drug use.183 These strategies share a common goal:
strengthening "protective factors" (i.e., well-developed social skills,
strong family bonds, attachment to school, and active involvement
in the community and religious organizations), while reducing "risk
factors" that increase vulnerability to drug abuse (i.e., substance
abuse by a parent, lack of parental guidance, disruptive, abusive
family relationships, school failure, early experimentation with
drugs, and living in a community where substance abuse and deal-
ing are pervasive). 84 Harm reduction education efforts usually en-
177. See id. ("Adulterant screening or 'pill testing' is an important harm reduction
service for Ecstasy users. Many tablets sold on the illicit market as 'Ecstasy' actually
contain substances far more dangerous than MDMA.").
178. Id.
179. Interview with Tim Santamour, Executive Director of DanceSafe in New
York, N.Y. (Sept. 17, 2001).
180. Id.
181. See GRAY, supra note 1, at 165 (posing questions about the effectiveness and
purposes of drug education); Jacob Sullum, Quit War, Legalize Drugs, USA TODAY,
Feb. 27, 1992, at 10A (discussing former drug czar William Bennet's view that there is
very little evidence that conventional antidrug education is effective).
182. DARE America, at http://www.dare.com/index2.htm (last visited Jan. 8, 2002).
183. See generally, CTR. FOR SUBSTANCE ABUSE PREVENTION, UNDERSTANDING
SUBSTANCE ABUSE PREVENTION, TOWARD THE 21ST CENTURY: A PRIMER ON EFFEC-
TIVE PROGRAMS (1999).
184. Id. The reasons adolescents begin using drugs vary, depending on individual
history, social influences, family dynamics and environmental influences. DRUG
STRATEGIES, KEEPING SCORE 8 (1997).
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compass "safer-use" campaigns meant to inform current users of
accurate risks. 18
5
C. "Ecstasy"
1. Development and Use
The drug commonly known as Ecstasy is actually the chemical
compound 3,4-methylenedioxymethamphetamine. 186 It was first
patented by the German pharmaceutical company Merck in 1914
as an intermediate chemical used in the process of synthesizing a
medicine intended to stop bleeding. 187 Until 1953, Ecstasy ap-
peared only twice in scientific literature, as a side product of chem-
ical reactions. 88 The Army Chemical Center then funded secret
testing on animals of various psychotropic chemicals, including Ec-
stasy, for their potential as brainwashing weapons.18 9 This research
yielded no significant results and the use of Ecstasy for such pur-
poses was abandoned. 19° In 1976, therapists started using small
quantities of Ecstasy to augment their patients' psychotherapy,
claiming it heightened self-insight and empathy.1 91 The therapists
called the drug "Adam"'192 and found it to be particularly beneficial
in facilitating communication, acceptance, and fear reduction.193
None of their research was officially documented or published,
however, because they feared that publishing preliminary findings
would ensure criminalization of this still legal drug, thereby block-
ing further research.' 94 Later, a lack of documented research
185. See Harm Reduction Coalition, Principles of Harm Reduction, at http://
www.harmreduction.org/prince.html (last visited Apr. 17, 2002) (discussing the need
for accurate information about drugs and drug use, including their adverse and harm-
ful effects); DIANE RILEY, CANADIAN CTR. ON SUBSTANCE ABUSE, THE HARM RE-
DUCTION MODEL: PRAGMATIC APPROACHES TO DRUG USE FROM THE AREA
BETWEEN INTOLERANCE AND NEGLECT 1 (1993) (claiming that research has shown
that users will change their behavior in response to information about safer use).
186. BECK & ROSENBAUM, supra note 112, at 9.
187. Julie Holland, The History of MDMA, in ECSTASY: THE COMPLETE GUIDE,
supra note 34, at 11, 11.
188. See id.
189. See id.
190. See id.
191. See BECK & ROSENBAUM, supra note 112, at 14.
192. See Holland, supra note 187, at 11, 13 (explaining that therapists nicknamed
MDMA "Adam" because of the state of emotion and empathy of the user, likened to
that of Adam in the Garden of Eden).
193. Id. at 14; Charles S. Grob & Russell E. Poland, MDMA in SUBSTANCE ABUSE:
A COMPREHENSIVE TEXTBOOK 269-75 (1997) (discussing Ecstasy-augmented psycho-
therapy that improved self-esteem, communication ability, and capacity for empathy).
194. See BECK & ROSENBAUM, supra note 112, at 15.
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would be a factor in Ecstasy's classification as a schedule I
substance. 195
The first published human study of Ecstasy was released in
1978.196 Two chemists described its effects as "an easily controlled
altered state of consciousness with emotional and sensual over-
tones.' 1 97 One of the scientists introduced Ecstasy to some ther-
apists because of its promise in the psychotherapeutic process; thus
contributing to Ecstasy's underground therapeutic use.198 Recrea-
tional use of the drug grew in the mid-1980s, due in part to media
attention directed at this new "miracle drug."199 Although Ecstasy
was gaining popularity in Boston and Washington, D.C., the first
major hub of Ecstasy use in the United States was Dallas, Texas.2 °°
As the DEA became aware of the rampant use and distribution of
Ecstasy in Texas, it became concerned with the growing use of this
new, and somewhat unknown drug.20 1 In 1984, the DEA initiated
its first investigation into Ecstasy to decide whether it should be
treated as a controlled substance.20 2 Ironically, the media attention
given to the DEA's investigation spurred savvy drug dealers to get
involved with Ecstasy's black market distribution.20 3
Possibly in response to the DEA's actions, therapists who had
been using Ecstasy in their practices sponsored a meeting on Ec-
stasy in California in 1985.204 The professionals in attendance had
used Ecstasy in more than 1000 therapy sessions.20 5 Several profes-
sionals who later challenged the DEA's classification of Ecstasy as
a controlled substance participated in this meeting.20 6 Neverthe-
less, the federal government classified Ecstasy as an illegal sched-
195. See Final Scheduling Rule, supra note 39.
196. Holland, supra note 187, at 12.
197. Id.
198. Id.
199. See BECK & ROSENBAUM, supra note 112, at 15; Marsha Rosenbaum & Rick
Doblin, Why MDMA Should Not Have Been Made Illegal, in BETWEEN POLITICS AND
REASON: THE DRUG LEGALIZATION DEBATE, supra note 2, at 135, 140-41 (describing
the effect of a surge in media coverage of Ecstasy on its popularity for recreational
use).
200. See BECK & ROSENBAUM, supra note 112, at 18-19, 21.
201. Holland, supra note 34, at 8.
202. Final Scheduling Rule, supra note 39.
203. See Grob, supra note 44, at 554.
204. Holland, supra note 187, at 13.
205. Id. at 13.
206. See Julie Holland, Clinical Experience with MDMA-Assisted Psychotherapy,
An Interview with George Greer, M.D., in ECSTASY: THE COMPLETE GUIDE, supra
note 34, at 227; see also BECK & ROSENBAUM, supra note 112, at 22.
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ule I substance in 1985.207 That year marked the beginning of an
era aimed at stringent attempts to both understand and penalize
Ecstasy use.
2. The Science of Ecstasy
Ecstasy is 3,4-methylenedioxymethamphetamine, a semisyn-
thetic drug taken in pill form, that is related to amphetamines and
mescaline.20 8 Ecstasy's attractive effects include "euphoria, in-
creased physical and emotional energy, and heightened sensual
awareness." 20 9 Immediate, short-term, adverse effects may include
jaw tension, rapid heartbeat, teeth grinding, and dry mouth.2 10 Fre-
quent use may also result in muscle tension, anxiety, dysphoria,
and almost a total loss of the desired effects of the drug.211 Unlike
classic, physically addictive drugs, increasing the dosage of Ecstasy
after a tolerance has been established will not result in increased
euphoric sensation.212 Therefore, although some individuals use
Ecstasy frequently in the beginning, they eventually taper their use
to achieve maximum benefits.213 The number of deaths caused by
Ecstasy to date is unknown. A 60 Minutes special that aired in
2000 claimed that over 1100 people have died from the ingestion of
Ecstasy over the past few years, but this figure was later dis-
proved.14 Approximately fifteen fatalities per year have been re-
ported, and in each case death was caused by the overheating of
the Ecstasy user.215
Most proposals to use Ecstasy in controlled treatment protocols
from the mid-1980s to the present have been denied approval.216
The Swiss government, however, granted permission to a group of
clinical psychiatrists to treat their patients with Ecstasy from 1988
to 1993.217 Scientists eventually conducted a retrospective analysis
of results from the treatment, and the Ecstasy-augmented psycho-
207. Controlled Substances Act, 21 U.S.C. § 811 (1996).
208. Holland, supra note 201, at 8.
209. Gary L. Bravo, What Does MDMA Feel Like?, in ECSTASY: THE COMPLETE
GUIDE, supra note 34, at 21, 24.
210. Id.
211. Marsha Rosenbaum & Rick Doblin, Why MDMA Should Not Have Been
Made Illegal, in THE DRUG LEGALIZATION DEBATE, supra note 2, at 135, 143.
212. Id.; Bravo, supra note 209, at 27.
213. Rosenbaum & Doblin, supra note 211.
214. Marc Savlov, Countdown to Ecstasy: A New Drug for a New Millennium, Aus-
TIN CHRON., Jun. 9, 2000, at C1.
215. Grob, supra note 44, at 557.
216. Id. at 560.
217. Id.
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therapy of 121 patients indicated a high degree of treatment re-
sponse within acceptable safety parameters: most of the treated
patients had improved "clinical status" as a result of the Ecstasy-
assisted treatment.218  The majority of Ecstasy research in the
United States has been conducted on animals and those humans
who have previously engaged in recreational use of Ecstasy.219
Many claim that such research has been incomplete.22 °
Policy decisions hinge on whether Ecstasy is a neurotoxic sub-
stance, that is, one that poisons nerve tissue.221 Ecstasy operates in
the brain through three main neurochemical mechanisms: blockage
of serotonin reuptake,222 induction of serotonin release,223 and in-
duction of dopamine release. 224 The major concern is that in per-
forming these functions, Ecstasy causes damage to serotonin nerve
cells, resulting in the brain's inability to properly produce serotonin
long after the effects of the drug have faded.225 Serotonin neurons
are "thought to play a role in regulating mood, memory, sleep, and
appetite. ' 226 Congressional findings in two recent Ecstasy bills and
the Drug Enforcement Agency's Final Rules regarding Ecstasy's
classification in the CSA all mentioned its potential for causing
brain damage as a critical factor.227
The validity of this concern is hotly debated among members of
the scientific community. One report found an absence of certain
chemical markers that are indicative of neurotoxicity.228 In an-
218. Id.
219. Id. at 568, 573, 580 (explaining that recreational use of Ecstasy by the test
subject impacts the validity of the study because the quantity and quality of Ecstasy
used by these subjects cannot be determined, and many such test subjects have likely
engaged in recreational use of other substances).
220. Id.
221. RANDOM HOUSE WEBSTER'S COLLEGE DICTIONARY 909 (3rd ed. 1995)
(1991).
222. Serotonin is a vasoconstrictor that is present in high concentrations in some
areas of the central nervous system; reuptake is the process by which serotonin is
reabsorbed. STEDMAN'S MEDICAL DICTIONARY 1516 (24th ed. 1992) (defining
"uptake").
223. Id. at 1277 (defining "serotonin").
224. Id. at 421; Holland, supra note 187, at 29.
225. USSC Report, supra note 40, at 8-9.
226. Vermont Legislative Research Shop: Ecstasy (MDMA) (The University of Ver-
mont, Burlington, VT), Apr. 23, 2001 at http://www.uvm.edu/-vlrs/doc/ecstacy.htm
(last visited Apr. 25, 2002).
227. See generally The Ecstasy Anti-Proliferation Act of 2000, Pub. L. No. 106-310,
114 Stat. 1101 (codified as part of the Children's Health Act of 2000, 42 U.S.C.
§ 290aa-5b (2000)); The Ecstasy Prevention Act of 2001, S. 1208, 107th Cong. (2001);
Final Scheduling Rule, supra note 195; U.S. SENTENCING COMM'N, supra note 40.
228. JAMES P. O'CALLAGHAN, Ctr. for Disease Control and Prevention, Defining
Neurotoxicity: Lessons from MDMA and Other Amphetamines 1 (2001).
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other study, Ecstasy users demonstrated impairments in visual and
verbal memory.229 However, some studies indicate that, even if
Ecstasy does cause such brain damage, the brain's elasticity and
redundancy render the damage only temporary and insignificant.23 °
In contrast, one animal study showed that some damage persisted
after seven years, but it did not specify the quantity or quality of
such damage.231 Critics of this study cite the large quantities of
Ecstasy given to the test subject animals.232 If Ecstasy does pro-
duce neurotoxicity, researchers and therapists may be able to take
measures to reduce any damage.233 Some researchers have found
that using the doses that most people use results in slightly reduced
sleep, less impulsive behavior, and less hostility.234 In contrast to
most of the studies conducted involving large doses of Ecstasy, a
1993 study involved administering a low dose of Ecstasy to
monkeys every two weeks for four months; the Ecstasy produced
no effect on the subjects.235 This study was never published in
mainstream media.236
Prevention education and media reports documenting the conse-
quences of Ecstasy use are often misleading. During a special pro-
gram aired on MTV, a SPECT scan 237 of an Ecstasy user's brain
was shown.238 The areas of low blood flow were displayed as blank
spaces, while the areas of normal blood flow were shown as brain
tissue.239 This was misleading to many viewers because the areas of
229. "Ecstasy" Damages the Brain and Impairs Memory in Humans, NIDA NOTES
(NIDA, Washington, D.C.), Nov. 1999, at 10-11 (discussing a study wherein the per-
formance on standardized memory tests of Ecstasy users was measured against nonus-
ers and both groups performed within a normal range).
230. Id. at 10 (citing George Battaglia, et. al., MDMA Induced Neurotoxicity: Pa-
rameters of Degeneration and Recovery of Brain Serotonin Neurons, 19 PHARMACOL-
OGY, BIOCHEMISTRY, & BEHAV. 269, 269 (1988)).
231. Id.
232. Holland, supra note 187, at 19.
233. Matthew Baggott & John Mendelson, Does MDMA Cause Brain Damage?, in
ECSTASY: THE COMPLETE GUIDE, supra note 34, at 142 (claiming that, because the
possible long-term consequences of neurotoxicity are unknown, researchers and ther-
apists can reduce the risk of neurotoxicity by maintaining low temperatures and hu-
midity, and by keeping frequency and quantity of Ecstasy doses at a minimum).
234. Better Than Well: Society's Moral Confusion Over Drugs Is Neatly Illustrated
by Its Differing Reactions to Prozac and Ecstasy, THE ECONOMIST, Apr. 6, 1996, at 87.
235. Grob, supra note 44, at 563.
236. Id. at 563.
237. True Life: I'm on Ecstasy (MTV television broadcast, Nov. 30, 2000); Julie
Holland, MDMA Myths and Rumors Dispelled, in ECSTASY: THE COMPLETE GUIDE,
supra note 34, at 54, 56-57 (defining a SPECT scan as a single positron emission com-
puted tomography scan).
238. Id.
239. Id.
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low flow looked like patches of missing tissue.24 ° In reality, Ecstasy
does not destroy brain tissue.241 While one study has shown that
single doses of Ecstasy do cause decreased blood flow in certain
areas of the brain, any decrease is temporary.242
NIDA held a conference in July 2001 on the current state of Ec-
stasy research.243 At the conference, a University of Minnesota
study was presented which found that "Preliminary data analyses
suggest that ecstasy use may not be as detrimental to cognitive
function as has been previously reported. ' 244 Therapists claim that
Ecstasy can be used to treat depression, schizophrenia, and post-
traumatic stress disorder.245 Charles Grob, a physician at the Har-
bor-UCLA Medical Center, summarized the current state of
scientific research on Ecstasy: "In spite of substantial media cover-
age and millions of federal dollars for basic science research on
neural mechanisms for possible brain injury caused by Ecstasy, full
understanding of both its medical consequences and cultural im-
pact has remained elusive. '246
3. Ecstasy and Federal Laws
On July 27, 1984, the DEA published in the Federal Register its
intention to classify Ecstasy as a schedule I drug.247 In response, a
group of therapists, psychiatrists, and researchers secured legal
counsel and filed a letter requesting hearings on the matter.248 Five
hearing sessions were conducted before the DEA's administrative
law judge, Francis L. Young, over a period of eight months.249 The
240. Id.
241. Id.
242. Id. at 57.
243. MDMAIEcstasy Research: Advances, Challenges, Future Directions: A Scien-
tific Conference (July 2001), at http://www.nida.nih.gov/meetings/mdma/mdmapos-
tersl.html (last visited Apr. 24, 2002).
244. Karen L. Hanson & Monica Luciana, Neurocognitive Function in Recrea-
tional Users of MDMA (July 19, 2000) (unpublished study on file with the Depart-
ment of Psychology, University of Minnesota).
245. See, e.g., Jose Carlos Bouso, Using MDMA in the Treatment of Post-Traumatic
Stress Disorder, in ECSTASY: THE COMPLETE GUIDE, supra note 34, at 248; Julie Hol-
land, Using MDMA in the Treatment of Schizophrenia, in ECSTASY: THE COMPLETE
GUIDE, supra, at 273; June Reidlinger & Michael Montagne, Using MDMA in the
Treatment of Depression, in ECSTASY: THE COMPLETE GUIDE supra, at 261.
246. Grob, supra note 44, at 550.
247. Schedules of Controlled Substances Proposed Placement of 3, 4-Methylenedi-
oxymethamphetamine Into Schedule I, 49 Fed. Reg. 30210-01 (July 27, 1984).
248. Id.
249. Final Scheduling Rule, supra note 195.
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Administrative Law Judge ("AL") heard testimony from thirty-
three witnesses and received ninety-five exhibits into evidence. °
On July 1, 1985, during the course of the hearing, the DEA Ad-
ministrator placed Ecstasy into schedule I pursuant to recently en-
acted emergency scheduling provisions.2 5' It is no coincidence that
this legislation was passed just months before the DEA published
its intent to control Ecstasy in the Federal Register. 2  Emergency
scheduling "is intended [ ] to apply to what have been called 'de-
signer drugs,' new chemical analogs [sic] or variations of existing
controlled substances, or other new substances, which have a
psychedelic, stimulant or depressant effect and have a high poten-
tial for abuse. '253 The Final Report on temporary placement stated
that "the temporary placement is not meant to interfere with the
hearing. ' 254 At that point, however, the findings of the ALJ be-
came essentially meaningless because the DEA Administrator in-
dependently determined that Ecstasy posed such a threat to public
safety that leaving it unscheduled for six more months would be
objectionable.255 The DEA Administrator had already concluded
that this relatively new drug would be placed in schedule I, regard-
less of the ALJ's recommendation. 56
On May 22, 1986, the ALJ issued his Opinion and Recommenda-
tions regarding the scheduling of Ecstasy. 57 He recommended
that it be placed in schedule III after finding that Ecstasy:
1. has a currently accepted medical use in the U.S.;
2. has an accepted level of safety under medical supervision;
and
3. has less than a high potential for abuse. 8
250. Id.
251. 21 U.S.C. § 811(h)(1) (1996).
252. The Comprehensive Crime Control Act of 1984 amended the Controlled Sub-
stances Act to allow the Administrator of DEA to place a substance, on a temporary
basis, into Schedule I when necessary to avoid an imminent hazard to the public
safety. Comprehensive Crime Control Act of 1984, Pub. L. No. 98-473, 98 Stat. 1976
(1984) (codified as amended at 42 U.S.C. §§ 10601-10604 and scattered sections of 18
U.S.C. (1996)); United States Department of Justice, Drugs of Abuse, at http://
www.usdoj.gov/dea/concern/abuse/chapl/control/emerge.htm (last visited Apr. 25,
2002).
253. Final Scheduling Rule, supra note 195.
254. Id.
255. See generally Final Scheduling Rule, supra note 195.
256. See generally id.
257. Id.
258. Id.
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The ALJ found that "accepted medical use" is determined by
what is "actually going on within the health care community," not
by a substance's FDA approval status.259 In addition, the ALJ
found that the DEA did not meet its burden in establishing that
Ecstasy has a high potential for abuse.26 °
Although this ruling was issued almost two years after the
DEA's initial publication in the Federal Register, and after a pro-
longed series of hearings lasting for most of that time period, the
DEA Administrator reviewed the record and declined to accept
the recommendations of the ALJ.261 The Administrator claimed
there was substantial evidence to support the classification of Ec-
stasy in schedule 1.262 His main point of contention with the ALJ's
ruling was the definition of "approved medical use. ' 263 The Ad-
ministrator reasoned that FDA approval was dispositive of "ac-
cepted medical use," and any other meaning would make the FDA
application and approval process a sham.264 "The fact that a hand-
ful of physicians are of the opinion that a substance may have ther-
apeutic value is not an acceptable alternative to the thorough
clinical and preclinical evaluation which precedes approval of a
[new drug application]. 265 The Administrator was also persuaded
by the scientific research demonstrating Ecstasy's potential for
neurotoxicity, in spite of the conflict among scientists on this is-
sue.266 The 1983 World Health Organization recommendation that
Ecstasy be placed in schedule I of the Convention on Psychotropic
Substances. 67 The subsequent placement of Ecstasy into schedule
I by the United Nations Commission on Narcotics Drugs also influ-
enced the Administrator's decision.268
Lester Grinspoon, one of the psychiatrists who originally re-
quested the DEA hearings, petitioned the United States Court of
Appeals for the First Circuit to review the DEA's final rule.2 69 The
Court of Appeals only seriously considered the first claim of the
suit, that the Administrator applied the wrong legal standards for
259. Id.
260. Id.
261. Id.
262. Id.
263. Id.
264. Id.
265. Id.
266. Id.
267. Id.
268. Id.
269. Grinspoon v. DEA, 828 F.2d 881, 881 (1st Cir. 1987).
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"currently accepted medical use. '27 ° The court employed a stan-
dard of review based on congressional intent.271 Where that intent
is not unambiguously expressed in a statute, the court reviews an
agency's actions to determine if they are based on a "permissible
construction of the statute. '27 2 The Court held that the DEA Ad-
ministrator's finding was in direct conflict with the intent of the
Administrative Procedure Act and vacated the Administrator's de-
termination that Ecstasy be placed in schedule 1.273 This served
little purpose, however, because the court merely instructed the
Administrator to reconsider the classification of Ecstasy without
treating the absence of FDA approval as conclusive evidence that
Ecstasy has no accepted medical use.274 Therefore, the Adminis-
trator merely had to find another reason to hold that Ecstasy
lacked "acceptable medical use. '275  Ecstasy was permanently
placed in schedule I on March 23, 1988.276
In the last two years, Congress has attempted to deal with in-
creased use of Ecstasy among young people with a "tough on
crime" approach led by Senator Bob Graham (D-Fla).277 He intro-
duced the first bill to specifically address Ecstasy: the Ecstasy Anti-
Proliferation Act of 2000.278 This bill was enacted in September
2000 as a provision of the Children's Health Act of 2000.279 In a
version that was ultimately not enacted, the bill would have pun-
ished anyone who disseminated information about drugs if that
person had reason to believe that the information would be used to
commit an illegal act.280 This section was not adopted in the final
version, and the main function of the bill as amended is to mandate
that the United States Sentencing Commission prepare a report on
270. Id.
271. Id. at 884-85.
272. Id. at 885.
273. Id. at 898 (citing the Administrative Procedure Act, 5 U.S.C. §§ 551-559
(1996))
274. Grinspoon, 828 F.2d at 881, 891.
275. Id. at 898 ("[O]n remand, the Administrator will not be able to rely on lack of
FDA approval to demonstrate the absence of an accepted medical use.").
276. Schedules of Controlled Substances; Scheduling of 3, 4-Methylenediox-
ymethamphetamine (MDMA) Into Schedule I of the Controlled Substances Act; Re-
mand, 53 Fed. Reg. 5156-01 (Feb. 22, 1988).
277. See The Ecstasy Anti-Proliferation Act of 2000, 42 U.S.C. § 201 (2000); The
Ecstasy Prevention Act of 2001, S. 1208, 107th Cong. (2001).
278. The Ecstasy Anti-Proliferation Act of 2000, Pub. L. No. 106-310, 114 Stat. 1101
(codified as part of the Children's Health Act of 2000, 42 U.S.C. § 201).
279. Id.
280. The Ecstasy Anti-Proliferation Act of 2000, 106 S. 1208, § 6 (2000) (codified as
amended as part of the Children's Health Act of 2000, 42 U.S.C. § 201 (2000)).
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Ecstasy with the ultimate end of increasing penalties so they are
"comparable with the sentences for other drugs of abuse."'2 ' The
bill also appropriates ten million dollars for enforcement and pre-
vention activities, although ninety-five percent of this money will
likely be used for enforcement alone.282
Consequently, the United States Sentencing Commission
amended the Federal Sentencing Guidelines (the "Guidelines") in
May 2001 to reflect an increase in sentencing for Ecstasy related
2813crimes. In order to set penalties in cases involving multiple
drugs with different penalties, the Federal Sentencing Commission
has established the concept of "marijuana equivalency. '284 In this
scheme, the Guidelines use marijuana penalties as the common
standard to which all other drugs are related mathematically.285
For example, one gram of powder cocaine has a marijuana
equivalency of 200 grams.286 Twenty grams of powder cocaine
would be equivalent to 4000 grams of marijuana.287
The Commission issued a report explaining how its findings
about Ecstasy led to its decision to increase penalties signifi-
cantly.288 After considering more public commentary than had
ever been received by the Commission,289 it decided against
promulgating the published proposal to equate the penalties for
Ecstasy trafficking with the penalties for heroin trafficking. 290 In-
stead, the Commission voted for a penalty structure that is, gram
for gram, somewhat more severe than for powder cocaine.29' The
Commission chose a greater penalty structure for Ecstasy than for
powder cocaine because it found that:
1. unlike Ecstasy, powder cocaine is not neurotoxic;
2. powder cocaine is not aggressively marketed to youth in the
same manner as Ecstasy; and
281. The Ecstasy Anti-Proliferation Act of 2000, Pub. L. No. 106-310, 114 Stat. 1101
(codified as part of the Children's Health Act of 2000, 42 U.S.C. § 201 (2000)).
282. See id. It is worth noting that while the text of the bill alludes to prevention as
a priority, only $500,000 of the $10 million is specifically allocated for prevention ac-
tivities. Id.
283. See id.
284. See U.S. Sentencing Comm'n, supra note 46, at 5 n.1 (explaining the marijuana
equivalency chart located in U.S.S.G. § 2D1.1).
285. Id.
286. Id.
287. Id.
288. Id. at 2-3 (explaining the purpose and statutory directive prompting the
Report).
289. Id. at 4.
290. Id.
291. See id. at 4-5.
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3. powder cocaine is only a stimulant, but Ecstasy acts as both
a stimulant and a hallucinogen.292
The amended Guidelines increased sentences for Ecstasy traf-
ficking offenders by 115%, from an average of thirty-four months
to seventy-three months imprisonment.293 In its prison impact
model, the Sentencing Commission noted that 372 prison beds
would be required ten years after implementation, with 270 beds
required within five years.294 However, the prison impact model
admittedly understated the actual impact of the amendment; the
estimates reflected only sentence increases of an assumed constant
number of convicted offenders and no changes in law enforcement
activity or prevalence of use were factored into the impact
analysis.295
Senator Bob Graham introduced The Ecstasy Prevention Act of
2001 in the Senate on July 19, 2001 and Congress has not yet en-
acted the bill.296 This act aims to "combat the trafficking, distribu-
tion, and abuse of Ecstasy (and other "club drugs") in the United
States. '29 7 The Act proposes to add a section to the Public Health
Service Act that would give monetary incentives to state and local
governments to target club drug use.298 States and municipalities
could earn incentives by "passing ordinances restricting rave clubs,
increasing law enforcement on Ecstasy, and seizing lands under
nuisance abatement laws to make new restrictions on an establish-
ment's use."'299 The act also appropriates funds to various aspects
of Ecstasy interdiction and treatment.30 0 In total, the Act allocates
$24.5 million for law enforcement efforts directed at Ecstasy and
other club drugs. 30  Despite the Act's title, only $2.5 million of this
292. See id. at 5.
293. Ecstasy Prevention Act of 2001, S. 1208, 107th Cong. (2001t).
294. See id. at 16.
295. See id. at 6.
296. Ecstasy Prevention Act of 2001, S. 1208, 107th Cong. (2001). As of April 2002,
this Act has not been signed into law.
297. Id.
298. Id. § 506.
299. Id.
300. Id.
301. Id. $15 million is allocated for the director of the Office of National Drug
Control Policy to combat trafficking in high-intensity drug trafficking areas, including
assistance for investigative costs, intelligence enhancements, technology improve-
ments, and training. Id. $7 million is allocated for the director of the Office of Na-
tional Drug Control Policy to carry out the Free Media Campaign Act of 1998,
ensuring that the campaign addresses the reduction and prevention of abuse of Ec-
stasy and other club drugs. Id. $1.5 million is allocated for the National Institute on
Drug Abuse to conduct research and produce a report by January 2003 that evaluates
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amount is directed at treatment and education, which are the two
primary modes of prevention. 0 2 Currently, The Ecstasy Preven-
tion Act is pending before the Senate Judiciary Committee.
H. THE SPECTRUM BETWEEN PROHIBITION AND
LEGALIZATION: OPTIONS FOR ECSTASY POLICY
Since the repeal of alcohol prohibition, United States drug policy
has ironically been grounded in the belief that outlawing illicit
drugs and punishing their use with severe criminal penalties will
prevent their use.30 3 Government-sponsored harm reduction pro-
grams, such as abstinence-based prevention and treatment, have
accompanied criminal sanctions to varying degrees. 30 4 Grass roots
efforts have also incorporated safer-use programs in some commu-
nities.305 Nonetheless, the application and effectiveness of these
approaches to Ecstasy are still in flux. The current combination of
tactics, including increasingly severe penalties, private pill-testing,
and prevention, is failing.30 6 Although Ecstasy use accounts for
only a small percentage of all drug use in the United States, it is the
fastest growing substance of choice among teenagers. 30 ' Ecstasy-
related emergency room visits have been increasing and Ecstasy is
more readily available than ever before.30 8 No solution will elimi-
nate Ecstasy use, but the Government can aim to more effectively
and efficiently reduce Ecstasy use and related harms. An examina-
tion of how alternative approaches to drug policy are or could be
applied to Ecstasy, and the associated benefits and criticisms of
the effects that Ecstasy has on an individual's health. Id. $1 million is allocated to the
establishment and function of an Interagency Ecstasy/Club Drug Task Force that will
design, implement, and evaluate the education, prevention, and treatment strategies
of the federal government. Id.
302. Id.
303. See supra note 30 and accompanying text (explaining the punitive criminal
justice approach to drug policy that parallels alcohol prohibition).
304. For a complete discussion of the application of harm reduction programs in
the United States, see supra notes 158-85 and accompanying text.
305. For a complete discussion of the application of harm reduction programs in
the United States, see supra notes 158-85 and accompanying text.
306. Supra notes 36-38 and accompanying text.
307. Supra note 37 and accompanying text.
308. See Holland, supra note 187, at 19 (explaining that at a July 2000 DEA confer-
ence on club drugs, it was estimated that two million hits of Ecstasy were coming into
the United States each week, and that according to the 2000 Monitoring the Future
study, eleven percent of high school seniors had tried Ecstasy at some time); supra
note 37 and accompanying text (citing statistics for the increase in emergency room
visits related to Ecstasy use).
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such approaches, may prove useful in determining what, if any,
changes should be effected.
A. Prohibition and Federal Laws
1. Ecstasy's Placement In Schedule I
Since 1985, Ecstasy has been categorized as a schedule I sub-
stance in the Controlled Substances Act, the classification typically
reserved for the most dangerous drugs.3 °9 One of the most signifi-
cant effects of a drug's placement in schedule I is the limit placed
on its research, especially studies involving human subjects. 310 A
scientist wishing to conduct research on a schedule I substance
must register with the Attorney General and then obtain approval
from HHS and the FDA.311 HHS approval is based on the compe-
tency of the practitioner and the merits of the research protocol,3 12
while FDA approval often depends on designing a protocol that
has concrete measurable outcomes.313
Opponents of Ecstasy's schedule I classification argue that the
contradicting outcomes of current scientific research about the ef-
fects of Ecstasy should instigate more, not less, research. 314 The
current challenge in obtaining FDA approval for a study wherein
Ecstasy is administered to human subjects is in constructing a pro-
tocol with outcome measures that are concrete enough to be ac-
ceptable to the FDA.31 5 This requirement is difficult to meet
because the results of psychotherapy are often difficult to quan-
tify. 316 The problem with the available Ecstasy research on human
subjects is that it was conducted only on subjects who have used
Ecstasy recreationally in an uncontrolled setting.31 7 Given the un-
reliable purity level of street Ecstasy,31 8 and the number of study
309. Supra notes 251-76 and accompanying text (explaining the process by which
Ecstasy was placed into schedule 1).
310. Julie Holland, MDMA Research: Introduction, in ECSTASY: THE COMPLETE
GUIDE, supra note 34, at 295.
311. 21 C.F.R. § 1301.18 (1997).
312. Controlled Substances Act, 21 U.S.C. § 823 (1996).
313. See Holland, supra note 206, at 240.
314. BECK & ROSENBAUM, supra note 112, at 145.
315. See Holland, supra note 206, at 40.
316. Id. at 40.
317. See id. at 40.
318. Judith Holland, Minimizing Risk in the Dance Community: An Interview with
Emanuel Sferios, in ECSTASY: A COMPLETE GUIDE, supra note 34, at 163 ("[A] large
percentage of the pills being sold as Ecstasy ... do not contain MDMA.").
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participants who may be poly-drug users,3t 9 current study results
are neither accurate nor indicative of the damage, or lack thereof,
of low level use in a controlled setting.32 ° Moreover, the research
conducted by NIDA, some argue, is biased either in its content or
distribution.321 For example, in the Sentencing Commission's Re-
port, which was mandated by Congress, the United States Sentenc-
ing Commission ("USSC" or the "Commission") stated at several
points that it was instructed to report on the damage and danger
caused by Ecstasy use, regardless of evidence to the contrary.322
One example was the instruction by Congress that the Commission
report on the danger of the high concentration of Ecstasy in each
pill; the Commission found no evidence to support this claim.323
2. Amendment of the Federal Sentencing Guidelines for Ecstasy
In May 2001, the Federal Sentencing Guidelines were amended
to increase the federal penalties for trafficking in Ecstasy.324 The
amendment made the penalties for trafficking Ecstasy higher than
those for trafficking cocaine and only slightly lower than those for
heroin. Supporters of the increase believe that the changes gave
law enforcement another weapon with which to battle Ecstasy.325
The Department of Justice contends that additional punishment is
needed to curb the dramatic increase in the drug's use in recent
years.326 As the DEA remarked,
[T]hese new sentencing enhancements.., will arm federal drug
law enforcement with a valuable tool against Ecstasy traffickers
by increasing the likelihood of federal prosecution, allowing
more appropriate terms of imprisonment for mid and high level
319. Judith Holland, Giving MDMA to Human Volunteers in the United States: An
Interview with Charles Grob, in ECSTASY: THE COMPLETE GUIDE, supra note 34, at
333 (noting that Ecstasy research subjects often have extensive histories of multidrug
use).
320. See Holland, supra note 206, at 40.
321. See Grob, supra, note 44, at 563-79 (raising questions about several govern-
ment-sponsored studies of Ecstasy, and the dissemination of those studies showing
harm to the exclusion of at least one study demonstrating no negative effects follow-
ing low dose administration of Ecstasy).
322. See U.S. SENTENCING COMM'N, supra note 40, at 9.
323. Id. at 9.
324. Ecstasy Prevention Act of 2001, S. 1208, 107th Cong. (2001); 42 U.S.C. § 201(2000).
325. Press Release, U.S. Senator Bob Graham, Graham Hails New Ecstasy Guide-
lines, Which Go Into Effect Tomorrow (Apr. 30, 2001) (on file with author).
326. Peter Slevin, Sentencing Guidelines Toughened for Ecstasy, WASH. POST, Mar.
21, 2001, at A17 (discussing the contention that stricter punishment is necessary to
curb drug use).
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dealers, and providing more effective leverage in turning low
level distributors to assist in apprehending and prosecuting the
top level violators in Ecstasy trafficking organizations.327
During the U.S. Sentencing Commission's public comment pe-
riod, many critics openly opposed the increase.328 The Federation
of American Scientists issued a statement concluding that there is
"no justification, either pharmacologically or in policy terms" for
increased Ecstasy penalties.329 Scientists also fear that harsher
penalties will lead to increased production of counterfeit sub-
stances sold as Ecstasy in an attempt to meet the demand for Ec-
stasy without risking harsher sentences.3 This poses a serious
health risk to users.331 The new Guidelines also raise the concern
that young, first-time offenders engaged in Ecstasy trafficking will
spend more time in prison than violent criminals despite the fact
that over eighty-five percent of federal Ecstasy offenders have little
or no criminal history.332 Senator Bill Graham, sponsor of the sen-
tence-increasing Ecstasy Anti-Proliferation Act,333 stated that "The
new guidelines are aimed at punishing profiteers, not young people
who make a bad choice. '334 These groups, however, may be one
and the same. According to the USSC, over one-third of the fed-
eral offenders sentenced for Ecstasy offenses in 2000 were between
the ages of twenty-one and twenty-five; the average age of all fed-
eral Ecstasy offenders is twenty-seven.335
Increased penalties have also been critiqued from an economic
perspective. Strict enforcement advocates attack the supply side of
the drug trade with two goals: stopping the flow of drugs and re-
327. Joseph D. Keefe, Statement Before the Senate Governmental Affairs Com-
mittee, (July 30, 2001), at http://www.usdoj.gov/dea/pubs/cngrtest/ct073001.htm (last
visited Apr. 21, 2002) [hereinafter Statement of Keefe].
328. See U.S. SENTENCING COMM'N, supra note 40, at 4 (stating that the USSC
received hundreds of submissions during its public comment period opposing the in-
creased penalties).
329. Press Release, Drug Policy Alliance, Harsh New Federal Penalties for Ecstasy
Take Effect (Apr. 30, 2001) (on file with author).
330. Id.
331. Id.
332. Id.; see infra note 347 and accompanying text (comparing the average sentence
for a nonviolent drug with that of a charge for manslaughter).
333. The Ecstasy Anti-Proliferation Act of 2000, Pub. L. No. 106-310, 114 Stat. 1101
(codified as part of the Children's Health Act of 2000, 42 U.S.C. § 201 (2000)).
334. Bob Graham, Tuesday: A New Tool to Combat Ecstasy Epidemic, ORLANDO
SENTINEL, Apr. 30, 2001, at A17.
335. U.S. SENTENCING COMM'N, supra note 40, at 13 (noting that the average age of
a heroin or methamphetamine trafficker is thirty-three years old, while the heaviest
use of Ecstasy occurs among people ages eighteen to twenty-five).
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ducing supply to drive up prices.336 Proponents of strict enforce-
ment as a means of reducing drug use argue that current
interdiction efforts work because they increase the consumer
cost.337 In many cases, the consumer costs are raised ten to one
hundred times the manufacturing cost.338 However, strict enforce-
ment may actually fail to drive up the cost of Ecstasy. The profit
margin for Ecstasy is enormous; each pill costs two to twenty-five
cents to produce, and sells for ten to forty-five dollars on the
street.339 Ecstasy trafficking and dealing is enormously profita-
ble.34° Yet, the price increase does not affect the typically middle-
class Ecstasy purchaser. 341  A California magistrate judge com-
mented that arrests and incarcerations may simply clear the way
for newer, smarter Ecstasy traffickers. 342 The competing financial
cost to society is also a concern. The increased number of prison
beds,343 the cost of housing prisoners for longer periods,344 and the
336. CAULKINS, supra note 25.
337. Id.
338. Id.
339. PBS, Ecstasy Discussion Guide (2001), at http://www.pbs.org/inthemix/educa-
tors/ecstasy-guide.html (last visited Jan. 20, 2002); see also Press Release, U.S. Cus-
toms Service, U.S. Customs Service Commissioner Announces New Steps to Combat
"ECSTASY" Abuse and Trafficking (Mar. 13, 2000) (on file with author) (quoting
customs officials saying that "Profit is one of the driving forces behind the surge in
Ecstasy traffic. In Europe, Ecstasy tablets cost just a few pennies apiece to make.
Once the tablets reach a nightclub in the U.S., they can be sold for $20-$40 a
piece"); Luke Johnson, Increase in Use of "Club Drug" Ecstasy Poses Growing Risk,
WASHINGTON FILE, Jul. 27, 2000, at 1 (quoting the United States Department of State
as saying, "[T]he tablets-produced at very low cost, and sold to users for anywhere
between $20 and $40-offer a very high profit margin.").
340. See Ecstasy Spreads: Many Users Think It Is Safe. Not So, Say Scientists and
Police. Permanent Brain Damage?, Partnership for a Drug-Free America, Ecstasy and
Club Drugs Information Center, Dec. 1, 2001, at http://www.drugfreeamerica.org (last
visited Jan. 20, 2002) ("At one former Ecstasy factory [there was] a machine that can
produce 300 Ecstasy pills a minute. Assuming that it operates ten hours a day, seven
days a week, it can produce more than 1.2 million pills a week. The cost per pill for
manufacturers: 20 cents. On the street that pill is worth $20.").
341. NIDA Infofax, MDMA (Ecstasy), at http://www.nida.nih.gov/Infofax/ec-
stasy.html (last visited Jan. 20, 2002) (stating that Ecstasy use has spread to other
social settings and has become the drug of choice among white middle-class young
adults in Washington, D.C.); Statement of Keefe, supra note 327.
342. See GRAY, supra note 1, at 211 (quoting Magistrate Judge Ronald Rose as
saying, "There is just so much money to be made that the slim chance of being caught
is always worth the risk. Believe me, after 20 years as a prosecutor and judge, I can
assure you that we only catch the stupid ones.").
343. Supra notes 11, 14-15 and accompanying text.
344. GRAY, supra note 1, at 37. ("[lIt costs taxpayers between $20,000 and $30,000
to keep just one inmate confined for a year.").
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societal costs of mixing drug users and violent criminals in prison345
are all criticisms of the enhanced sentences for Ecstasy trafficking.
Families Against Mandatory Minimums, a nonprofit organization,
also criticizes such sentences for the harm families suffer when a
member is imprisoned for a lengthy period of time.346 The average
federal sentence for a drug offense is seventy-eight months, over
twice the average sentence for manslaughter.347 Disproportionate
sentencing for nonviolent drug offenses and violent offenses trou-
bles many, especially when it has yet to be proven that the sub-
stance in question causes serious harm.348
B. Harm Reduction
The harm reduction view, that drug use should be addressed as a
social and public health concern, 34 9 has gained public support in
recent years.350 This is likely due in part to the fact that 86.9 mil-
lion Americans over age twelve have used an illicit drug at least
once in their lifetime. 351 This is not to say, however, that law en-
forcement is not necessary in some circumstances. According to
Kurt Schmoke, the former mayor of Baltimore, Maryland, "Our
goal must be defined as finding the right balance of law enforce-
ment and public health strategy to achieve the goals that we hold in
common: safer communities, healthier individuals, reduced sub-
345. See id. at 29-30 (discussing the growing number of drug prisoners in the United
States and the unintended effects of forcing drug users to associate with criminals,
prison overcrowding, early release of violent offenders to make room for nonviolent
drug offenders serving mandatory minimum sentences, court docket backlog, and loss
of deterrent effect).
346. See Families Against Mandatory Minimums, at http://www.famm.org (last vis-
ited Jan. 20, 2002).
347. See Arianna Huffington, Bush's Drug Policy: "The Thing With Two Heads,"
ARIANNA ON LINE, May 17, 2001, at http://www.ariannaonline.com (last visited Jan.
20, 2002).
348. Supra notes 228-35 and accompanying text (discussing conflict among scien-
tists regarding the damage caused by Ecstasy).
349. Supra note 110 (defining harm reduction).
350. E.g., Diane Riley & Pat O'Hare, Harm Reduction: History, Definition, and
Practice, in HARM REDUCTION: NATIONAL AND INTERNATIONAL PERSPECTIVES,
supra note 19, at 9 (stating that harm reduction seeks to minimize harms to the indi-
vidual, the community, and society as a whole by approaching drug use as a public
health issue, while respecting individuals' choices); Jefferson Fish, Rethinking Our
Drug Policy, 28 FORDHAM URB. L.J. 48, 49-50 (2000) (explaining that harm reduction,
or medicalization, treats drug use primarily as a public health issue).
351. SUBSTANCE ABUSE AND MENTAL HEALTH SERVS. ADMIN., U.S. DEP'T OF
HEALTH AND HUMAN SERVS., SUMMARY OF FINDINGS FROM THE 2000 NATIONAL
SURVEY ON DRUG ABUSE 131 (2001).
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stance abuse, and the elimination of AIDS. '352 While many harm
reduction advocates would agree with these goals, they would not
support the balance Schmoke proposes.353 In fact, many harm re-
duction advocates believe that the primary use of the criminal jus-
tice system as a method to deal with drug use should be eliminated
entirely. 4 Others claim that as long as drug use is treated through
the punitive criminal justice system, harm reduction methods
should be used to humanize the system itself.355 The advantages
and disadvantages of such methods-treatment, prevention, and
safer-use programs-can be most clearly evaluated individually.
1. Treatment
Treatment is the "use of any planned, intentional intervention in
the health, behavior, or personal life of an individual suffering
from alcoholism or from another drug dependency to enable the
individual to achieve and maintain sobriety and physical and
mental health.356 Drug treatment is seven times more cost effec-
tive than domestic law enforcement in addressing drug abuse.357
There are approximately 800,000 prison inmates nationally who
have drug and alcohol abuse problems, but only one in six receives
any kind of drug treatment at all.358
Treatment is widely accepted as a viable and effective solution to
the problem of substance abuse.359 The few critics of this solution
mainly question the validity of the "disease model" of addiction.36 °
352. Fish, supra note 350, at 48.
353. Harm Reduction Coalition, Principles of Harm Reduction, http://www.har-
mreduction.org/prince.html (last visited Apr. 10, 2002) (discussing the negative results
of the drug control strategy that prioritizes criminalization).
354. Id.
355. James A. Inciardi, The Harm Reduction Roles of the American Criminal Justice
System, in HARM REDUCTION: NATIONAL AND INTERNATIONAL PERSPECTIVES, supra
note 19, at 199.
356. Am. Soc'y for Addiction Med., Public Policy Statement, Treatment for Alcohol-
ism and Other Drug Dependencies, at http://www.asam.org/ppol/treatment.htm (last
visited Jan. 20, 2002).
357. A Cheaper Way to Fight Cocaine, S.F. CHRON., June 14, 1994, at A7.
358. GRAY, supra note 1, at 185.
359. See, e.g., Steven Belenko, The Challenges of Integrating Drug Treatment into
the Criminal Justice Process, 63 Albany L. Rev. 833, 837 (2000) (discussing the re-
search demonstrating that drug treatment can significantly reduce drug use and re-
lated crime); Bernadette Pelissier et. al., Triad Drug Treatment Evaluation Project, 65
FED. PROBATION 3 (2001) (stating that drug treatment provided to incarcerated of-
fenders reduces the likelihood of future criminal conduct and drug use).
360. For a general discussion of the disease model of addiction, see Bruce K. Alex-
ander, The Disease and Adaptive Models of Addiction: A Framework of Evaluation, in
VISIONS OF ADDICTION 45 (Stanton Peele ed., 1988).
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The current "drug czar," John Walters, supports treatment as a
companion to increased enforcement and longer periods of incar-
ceration, but has also accused treatment advocates of being dog-
matic and has questioned the concept of addiction as a disease.361
Treatment is sometimes encouraged or mandated in criminal pos-
session cases in which the defendant engaged in only casual or rec-
reational use.362 Moreover, court-ordered treatment rests on the
premise that every illicit substance user is addicted and in need of
abstinence-based treatment.363 However, treatment professionals
point out that "Everyone who uses a drug is not an addict, at least
not yet.
364
Ecstasy is a nonaddictive substance, but repeated use can lead to
psychological dependence.365 Psychological dependence is charac-
terized by a desire to engage in repeated use, without the compul-
sive nature of physical addiction.366 Treatment for nonaddictive
substances like Ecstasy is very different from treatment for physi-
cally addictive substances such as cocaine, alcohol, and heroin.367
In contrast to these substances, Ecstasy dependency occurs because
of the mental and physical euphoria felt when under its influ-
ence.368 Consequently, treatment professionals face a challenge in
determining how to appropriately handle Ecstasy users, and have
not accepted any single protocol.
361. See John P. Walters, Just Say No... To Treatment Without Law Enforcement,
WKLY. STANDARD, Mar. 6, 2001, at 19 ("The therapy-only lobby is alive and well and
more dogmatic than ever. If it weren't for the ideology associated with treatment-
addiction is a disease, not a pattern of behavior for which people can be held respon-
sible-law enforcement and punishment would be natural partners of the treatment
providers (remember Marion Barry, whose treatment followed his arrest).").
362. DAVID A. PETERS, THE PROBABILITY OF ADDICTION 6 (1997).
363. Id.
364. Id.
365. Supra notes 212-13 and accompanying text (explaining how abuse of Ecstasy
might occur and correct itself, rendering Ecstasy only psychologically addictive).
Contra Facts about MDMA (Ecstasy), NIDA NOTES (NIDA, Washington, D.C.),
2000, at 1 (stating that Ecstasy is addictive).
366. Psychological dependence, or habituation, is the result of repeated consump-
tion of a drug that produces psychological but no physical dependence. U.S. Dep't of
Labor, Working Partners Substance Abuse Database, Glossary of Terms, at http://
www.notes.dol.gov/said.nsf (last visited Apr. 24, 2002). The psychological dependence
produces a desire (not a compulsion) to continue taking drugs for the sense of im-
proved well-being. Id.
367. Physical addiction occurs when a person's chemical usage causes repeated
harmful consequences and the person is unable to stop using the drug of choice; the
term implies that withdrawal will take place when the mood changing chemical is
removed from the body. Id.
368. Alcohol Drug Treatment Referral, Drug Information: Ecstasy, at http://
www.nationalhotline.org/ecstasy.html (last visited Apr. 24, 2002).
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In September 2001, the Maryland legislature issued an action
plan that incorporated treatment methods into its efforts to
counteract the increasing number of teenagers using Ecstasy.369
This plan includes training county treatment providers and preven-
tion educators, educating hospital and emergency room personnel
to ensure that an Ecstasy episode is properly treated, and issuing
alerts to increase awareness of Ecstasy's effects within the medical
and treatment communities.37 ° One researcher recommends psy-
chotherapy and a careful examination to determine if a user took
Ecstasy to self-medicate an underlying disorder, such as depression
or anxiety, which should be treated separately.37' Treatment for
Ecstasy would include the same elements used to treat addiction or
dependence on other substances; it is a generally accepted notion
among treatment professionals that the overall addiction, whether
physical or psychological, is the problem, not the specific sub-
stance.372 It should be noted, however, that not all drug users be-
come addicts, and addiction treatment may prove unnecessary
within this population.373
2. Prevention
Advocates of almost every approach to drug policy respect pre-
vention education, but selection of specific prevention methods en-
genders great disagreement. Preventing alcohol, tobacco, and
other drug use among the nation's children was the first of five
goals outlined last year in the National Drug Control Strategy. 374
However, the Federal government allocated only thirteen percent
of its drug budget to prevention programs and research.375 Preven-
tion spending lags at the state level as well, where only twenty per-
369. MD. CABINET COUNCIL ON CRIMINAL AND JUVENILE JUSTICE, STATE Ec-
STASY ACTION PLAN (2001).
370. Id.
371. Karl L.R. Jansen, Mental Health Problems Associated with MDMA Use, in Ec-
STASY: THE COMPLETE GUIDE, supra note 34, at 106-07.
372. Ecstasy (DrugAbuse.com), at http://www.drugabuse.com/drugs/ecstasy/ (last
visited Apr. 24, 2002).
373. Robert Curley, Addiction Insights, ALCOHOLISM AND DRUG ABUSE WKLY.,
Apr. 3, 1995, at 3 (stating that only a small percentage of drug users need addiction
treatment).
374. OFFICE OF NAT'L DRUG CONTROL POLICY, NATIONAL DRUG CONTROL
STRATEGY: 2001 ANNUAL REPORT 6-7 (2001).
375. Id.
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cent of state drug budgets address both prevention and
treatment.376
a. Traditional Prevention Programs
There are two prominent abstinence-only prevention programs
in the United States: Drug Abuse Resistance Education
("DARE") and Life Skills Training ("LST"). 377 A study found
DARE to be ineffective in February 2001, yet eighty percent of the
nation's school districts still utilize the DARE program.378 More
than one dozen experts describe this drug education movement as
dysfunctional and highly politicized.379 They also describe it as a
program that does not stand up to scientific scrutiny.380 These ex-
perts believe that the abstinence-based model of drug prevention
education used in America's schools is as likely to have no effect
on minors' drug use, or even the unwanted effect of inciting curios-
ity, as it is to persuade them not to use drugs.381
A popular alternative to DARE is LST, a program consisting of
a three-year curriculum beginning in sixth or seventh grade.382 The
program covers three general topics: the effects of drugs on the
body, the development of personal or self-management skills, and
the honing of students' social and resistance skills.383 LST statistics
show a reduction in the use of alcohol, tobacco, and marijuana
among program participants by as much as seventy-five percent,
and a significant decrease in the use of narcotics and halluci-
nogens.384 The Department of Education, NIDA, and the Center
376. Id.; M. A. R. Kleiman, Drugs and Drug Policy: The Case for a Slow Fix, 15
ISSUES IN SCI. AND TECH. 1 (1998).
377. DARE is a police officer-led series of classroom lessons for children from kin-
dergarten through twelfth grade. DARE, http://www.dare.com (last visited May 11,
2002); LST targets middle and junior high school students and consists of a three-year
curriculum comprising fifteen sessions in the first year, ten sessions in the second year,
and five to eight sessions in the third year. DRUG STRATEGIES, CRITICAL CHOICES:
MAKING DRUG POLICY AT THE STATE LEVEL 1 (2001).
378. Donald R. Lynam & Richard Milich, Project DARE: No Effects at 10-Year
Follow-Up, 67 J. OF CONSULTING & CLINICAL PSYCHOL. 590, 592 (1999) ("[T]here
appear to be no reliable short-term, long-term, early adolescent, or young adult posi-
tive outcomes associated with receiving the DARE intervention."); DARE, http://
www.dare.com/index2.htm (last visited Apr. 23, 2002) (stating that DARE is still
taught in the majority of school districts in the country).
379. Lyman & Milich, supra note 378, at 592.
380. Id.
381. Id.
382. DRUG STRATEGIES, CRITICAL CHOICES: MAKING DRUG POLICY AT THE
STATE LEVEL 1 (2001).
383. Id.
384. Id.
2178
AGONY OF ECSTASY
for Substance Abuse Prevention have all deemed DARE exem-
plary.385 The program is taught in approximately 3000 schools, and
has produced over 800,000 alumni.386
The Center for Educational Research conducted a study in 2001
that criticized LST's data and methods for calculating effectiveness,
finding that students who did not complete the entire three-year
curriculum had higher drug use rates than those who never en-
countered the program.387 A former researcher on one LST study
found that students who went through LST were more likely to
drink alcohol than students who were not exposed to the
program.388
Abstinence-only prevention programs have drawn sharp criti-
cism from many in the scientific community and the national gov-
ernment. The General Accounting Office, which evaluates how
effectively federal money is spent, reported that "There is no evi-
dence that the no use approach is more successful than alternative
approaches, or even successful in its own right. '389 A more general
criticism of widely used prevention programs such as DARE and
LST is that drug education researchers often evaluate their own
programs, and, with few exceptions, tend to parse out their data so
programs appear more successful than they actually are.39 ° While
"Just Say No" programs may work for very young children, they
are largely ineffective for teenagers and young adults.
391
b. Alternative Prevention Programs
An alternative prevention education program called "resilience
education" focuses on young people's ability to adapt and thrive
within the current drug culture, without teaching that abstinence is
the only response.392 As many as seven million children between
the ages of ten and seventeen are at particularly high risk because
of personal, family, or community factors.393 As such, supporters
of this program hail it as a more realistic approach than no-use
programs. Marsha Rosenbaum, West Coast director of the Drug
385. Jason Cohn, Drug Education: The Triumph of Bad Science, ROLLING STONE,
May 24, 2001, at 41.
386. Id.
387. Center for Educational and Resource Development, http://www.cerd.org/cur-
rent/jde2001.html (last visited Apr. 23, 2002).
388. Cohn, supra note 385, at 41.
389. Id.
390. Id.
391. Rosenbaum, supra note 36, at B9.
392. Id.
393. DRUG STRATEGIES, KEEPING SCORE 8 (1997).
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Policy Alliance, notes, "What's missing from 'drug education' is ed-
ucation. For the kids who don't say no, where can they go for hon-
est, realistic information about drugs in a life-or-death situation?
They sure can't go to the so-called educator in a no-use prevention
program. '
394
Another alternative prevention program is New York's Student
Assistance Program ("SAP"), which encourages young people to
seek counseling for anything that might lead to alcohol or drug
use. 395 This program, in place since 1979, offers confidential assis-
tance for all students, regardless of whether or not they have begun
experimenting with drugs.396 While offered to all students, the pro-
gram most often benefits at-risk students.397 Evaluations since
1983 indicate that SAP reduces teenage use of alcohol and other
drugs by up to fifty percent.398 The positive results are attributed
to individualization of the program at each participating school.399
Prevention programs specifically targeting Ecstasy use have been
initiated by NIDA, but many educators still cannot determine
which efforts will be most effective at reducing use °.4  The Na-
tional Clearinghouse for Alcohol and Drug Information simply
writes, "In developing prevention efforts that target young people,
prevention managers must design strategies to counter the increas-
ing use and widespread availability of the club drug Ecstasy. 40 1
The strategies that can counter the growing Ecstasy use are likely
the same ones used to counter other drugs. In an in-depth study of
prevention programs, NIDA found that the most effective preven-
tion programs enhance "protective factors" such as positive family
relationships, community involvement, and success in school, while
394. Id.
395. Id.
396. Id.
397. Behavioral Health Services North, School-Based Services, at http://
www.bhsn.org/bhsn8.htm (last visited Apr. 24, 2002).
398. DRUG STRATEGIES, supra note 393.
399. Id.
400. For example, on its website, NIDA shows the image of a brain and describes
one half as being a normal brain (with the correct serotonin production), and the
other half being damaged by repeated Ecstasy use. NIDA, http://nida.nih.gov. This
image has been widely criticized because people generally vary in their serotonin pro-
duction, and the Ecstasy user may have used other drugs prior to the scan. Club
Drugs.org, http://165.112.79.54/ (last visited Apr. 24, 2002). NIDA also attempts to
educate elementary school students on the effects of various drugs, including Ecstasy,
on the brain and body with cartoon images and simple-to-read text. NIDA, http://
165.112.78.61/MOM/HALL/MOMHALL1.html (last visited Apr. 24, 2002).
401. Prevention Works!, The National Clearinghouse on Alcohol and Drug Abuse
at http://www.health.org/govpubs/prevalert/v3i25.htm (last visited Apr. 24, 2002).
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moving toward reversing or reducing known "risk factors" such as
chaotic home environments, lack of mutual attachments, lack of
nurturing, and poor social coping skills.4 °2
3. Safer-Use Programs
Part of a comprehensive harm reduction plan to address the in-
crease in Ecstasy use should include safer-use programs that edu-
cate the public on the risks of using Ecstasy and provide
information about how to use it more safely.4 °3 In the early 1990s,
the rave community began its own safer-use campaign by develop-
ing a code of conduct for rave organizers. 4  This campaign in-
cludes emphasizing the provision of "chill out" rooms,40 5 easy
access to cold water, and the distribution of drug risk informa-
tion.406 Harm reduction advocates willingly acknowledge that Ec-
stasy, like any other drug, is not safe,40 7 but claim that "young
people are clamoring for, and listening to, recommendations for
reducing immediate harm. ' 40 8 Such recommendations include the
following: resting periodically to prevent overheating; drinking
water; testing pills to be sure they do not contain dangerous adul-
terants; avoiding combining Ecstasy with other drugs; and moder-
ating dose levels and frequency of use.4 09 DanceSafe,410 for
example, disseminates drug risk information and provides an extra
service, adulterant testing, at clubs and raves or by mail.411
Advocates claim that adulterant testing is an important compo-
nent of the safer use of Ecstasy. 412 By the mid-1990s, only an esti-
402. NIDA Infofax, Lessons from Prevention Research, at http://165.112.78.61/In-
fofax/lessons.html (last visited Apr. 24, 2002).
403. Supra note 174 and accompanying text.
404. Gwen Filosa, Rave Promoters Feel the Heat, NEWHOUSE NEWS SERVICE, Mar.
13, 2001, at 1.
405. "Chill out" rooms are rooms provided at raves or clubs where patrons can go
to cool down. Id.
406. Grob, supra note 44, at 558.
407. See P'ship for a Drug-Free Am., Ecstasy and Club Drugs Info. Ctr., Ecstasy
Spreads: Many Users Think It Is Safe. Not So, Say Scientists and Police. Permanent
Brain Damage?, Dec. 1, 2001, at http://www.drugfreeamerica.org (last visited Apr. 23,
2002) (quoting Emanuel Sferios, the founder of DanceSafe, stating: "No drug use is
safe").
408. Rosenbaum, supra note 36, at B1l (emphasis added).
409. Id.
410. Supra notes 175-80 and accompanying text (explaining the establishment and
purpose of DanceSafe).
411. Promoting Health and Safety in the Rave Community (DanceSafe), at http://
www.dancesafe.org (last visited Apr. 24, 2002); see also supra notes 175-180 and ac-
companying text.
412. Promoting Health and Safety, supra note 411.
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mated forty percent of pills sold as Ecstasy were actually
Ecstasy.4"3 Although statistics have not yet been compiled,
DanceSafe offers anecdotal evidence of the effectiveness of its ef-
forts.414 In the summer of 1999, DanceSafe discovered through its
pill-testing program that tablets containing dangerously high doses
of DXM415 were causing the majority of medical emergencies in
the Oakland rave community, as well in many other cities across
the U.S.416 DanceSafe was able to warn users about this increased
risk.417 Another dangerous adulterant is PMA.418 PMA precursor
chemicals are easier to obtain and are not strictly controlled by the
government like those for Ecstasy; as such, someone can produce
PMA without taking the risks of producing real Ecstasy.419 Al-
though DanceSafe's standard testing cannot identify PMA, the or-
ganization's website provides a picture of a PMA pill and warns
readers to avoid it because of its danger.420
Despite evidence that safer-use campaigns actually reduce harm,
many critics still oppose them because of their potential message:
that Ecstasy use is acceptable and safe under certain circum-
stances.42' Dr. Alan I. Leshner, director of the National Institute
on Drug Abuse, has said, "I'm against anything that sends a mes-
sage that if you do it well it is O.K., because it is not O.K. '422 A
legislative aide to Senator Bob Graham, who authored the two
413. Grob, supra note 44, at 558.
414. Interview with Tim Santamour, Executive Director of DanceSafe in New
York, N.Y. (Sept. 17, 2001).
415. DXM is the abbreviation for dextromethorphan, a legal cough suppressant
that in high doses can prevent sweating. DanceSafe, http://www.dancesafe.org (last
visited Apr. 24, 2002).
416. Filosa, supra note 104, at 1.
417. Id.
418. See The Nat'l Clearinghouse for Alcohol and Drug Info., The Hallucinogen
PMA: Dancing With Death, Oct. 2000, at http://www.health.org/nongovpubs/pma-dea/
(last visited Apr. 24, 2002) (stating that paramethoxyamphetamine (PMA), is an il-
licit, synthetic hallucinogen that has stimulant effects similar to other clandestinely
manufactured amphetamine derivatives like MDMA. Since May 2000, PMA ingestion
has been associated with three deaths in Chicago, Illinois, and seven deaths in central
Florida).
419. See, e.g., DanceSafe, PMA Warning, at http://www.dancesafe.org/pma-faq.
html#intro (last visited Apr. 24, 2002).
420. Id.
421. Id. In addition, one toxicology expert criticized DanceSafe's on-site testing be-
cause such testing is not conducted in a sterile environment and the testers do not
have the relevant specialized degrees. Party Drug, Fatal Drug (CBSNews broadcast,
Jul. 26, 2001), at http://www.cbsnews.com/stories/2000/11/29/48hours/main253290.
shtml (last visited Apr. 24, 2002).
422. Jeff Stryker, For Partygoers Who Can't Say No, Experts Try To Reduce the
Risks, N.Y. TIMES, Sept. 25, 2001, at F5.
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congressional bills targeting Ecstasy,423 claims that "Arguably, or-
ganizations such as DanceSafe promote Ecstasy use. These organi-
zations are giving a mixed message, a very dangerous message to
people who use this drug.
424
C. Decriminalization
Some consider decriminalization a lesser form of legalization
where criminal sanctions for users are removed while those for
manufacturers and sellers remain intact.425 "Decriminalization"
typically means that a person can legally possess a small quantity
(enough for personal use only) of a given drug, or that penalties for
drug possession are reduced.426 A primary concern about
decriminalization is that it will lead to increased usage.427 How-
ever, the decriminalization of marijuana by eleven states in the
United States during the mid-1970s does not appear to have caused
increases in marijuana consumption.428
Some decriminalization of Ecstasy has already occurred in the
United States.429 At the state and local level, low-level Ecstasy
possession has not been enforced consistently.430 DanceSafe nego-
tiates with local police to give volunteer testers and Ecstasy users
amnesty from arrest.431 This reprieve allows DanceSafe to perform
services that could otherwise lead to massive arrests.432 Further
decriminalization of Ecstasy could involve reducing penalties for
possession and entering into formal agreements with law enforce-
ment agencies not to enforce low-level possession violations.
D. Legalization with Regulation
Legalization is often misunderstood. As most advocates define
it, legalization involves the repeal of laws prohibiting drug use and
the implementation of regulated system of Ecstasy distribution
423. See supra notes 278-302 and accompanying text (discussing The Ecstasy Pre-
vention Act of 2001 and The Ecstasy Anti-Proliferation Act of 2000).
424. Stryker, supra note 422, at F5.
425. Ethan A. Nadelmann, Drug Prohibition in the United States: Costs, Conse-
quences, and Alternatives, 245 SCIENCE 939, 939-47 (1989).
426. For a complete definition of decriminalization, see supra note 119 and accom-
panying text.
427. Nadelmann, supra note 425, at 939-47 (citing L. D. Johnston, J. G. Bachman &
P.M. O'Malley, Marijuana Decriminalization: The Impact on Youth 1975-1989 (1981).
428. Nadelmann, supra note 425, at 939-47.
429. Stryker, supra note 422, at F5.
430. Id.
431. Id.
432. Id.
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similar to that which currently exists for alcohol and cigarettes,
with state-run sales, quality and price control, and regulated adver-
tising.4 33 The goal of such legalization is to undercut the criminal
element.434 Advocates claim that legalization would reduce health
risks to users because pills would be tested as part of the regulation
process; only a set strength and purity level would be available for
purchase.435 Advocates also cite the high financial cost and ineffec-
tiveness of the drug war as reasons for legalization. In addition to
the Office of Drug Control Policy's annual budget, "It costs ap-
proximately $8.6 billion per year to keep drug law violators behind
bars. '436 Drug-related criminal and medical costs total over $67
billion, and almost seventy percent of that is attributable to drug-
related crime.437 While legalization may initially drive drug use up,
proponents argue that any such increase would taper off and the
net result would be less harm than exists under the current prohibi-
tion-based drug policy.438 Some argue that legalization would re-
duce crimes committed indirectly because of drug use, such as
those related to the black market for drug sales which has devel-
oped in response to drug prohibition.439
However, legalization is not considered a viable solution by most
advocates of the punitive criminal justice approach.440 This is best
expressed in the Anti-Drug Abuse Act of 1988: "The Congress
finds that legalization of illegal drugs, on the federal or state level,
is an unconscionable surrender in a war which, for the future of our
433. See GRAY, supra note 1, at 213-14 (discussing regulated distribution and legali-
zation); see generally DIRK CHASE ELDREDGE, ENDING THE WAR ON DRUGS (1998)
(explaining how regulated distribution would function).
434. Id.
435. See Ethan Nadelmann, How to Legalize: An Interview with Emily Yoffe,
MOTHER JONES (Feb./Mar. 1990), at 18-19, available at http://www.lindesmith.org/li-
brary/tlchowto.html (last visited Apr. 22, 2002) (discussing how a substance like co-
caine might be regulated in a legalization framework).
436. Bureau of Justice Statistics, Prisoners in 1996, 1997, at 10-11, at http://
www.drugwarfacts.org/economi.htm (last visited Apr. 22, 2002).
437. National Drug Control Strategy 2000 Annual Report (Office of National Drug
Control Policy 2000), at 66, http://www.drugwarfacts.org/economi.htm (last visited
Apr. 25, 2002).
438. See Nadelmann, supra note 435, at 18.
439. William Raspberry, The Delusional Drug War, WASH. POST, May 4, 2001, at
A25 ("[Miuch of the harm we attribute to drugs-including gang warfare, police cor-
ruption and murder-results not from the drugs themselves but from our efforts to
prohibit drugs."). In 1993, then Surgeon General Joycelyn Elders said, "I do feel that
we would markedly reduce our crime if drugs were legalized." MusTo, supra note 59,
at 282.
440. See supra notes 4-5 and accompanying text; see also The Anti-Drug Abuse Act
of 1988, PL No. 100-690, 102 Stat 4181, § 5011 (codified as 21 U.S.C. 1501).
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own country and the lives of our children, there can be no substi-
tute for total victory." 441 The DEA opposes legalization because it
would likely (1) "reduce the perception of the risks and costs of
drug use; (2) increase availability of and access to harmful drugs;
(3) increase demand, use, abuse, and addiction; and (4) remove the
social sanction against drug abuse that is reinforced in legisla-
tion. ' 442 A pamphlet published by The Partnership for a Drug-
Free America warns that even considering or discussing legaliza-
tion as a viable option may contribute to higher drug use among
young teenagers.443
Opponents to legalization also include within their ranks some
advocates of decriminalization. Two public policy professors at the
University of California acknowledge that many of the harms cur-
rently associated with drugs are due to their illegality, but they
maintain that legalization would increase drug use. 444 This increase
would result from price reductions following elimination of the
black market inflationary impact on the price of drugs; even incor-
porating taxes and transaction costs into the regulated price would
result in a significant price reduction.445
I. A HYBRID PLAN FOR ECSTASY POLICY
The United States' "war on drugs" has fostered a fear-based Ec-
stasy policy that is ineffective, costly, and dangerous. 46 Ecstasy
use continues to increase and its long-term harms are clearly
known, yet lawmakers continue to respond with increasing punish-
441. The Anti-Drug Abuse Act of 1988, PL No. 100-690, 102 Stat 4181, § 5011
(codified as 21 U.S.C. 1501).
442. UNITED STATES DEPARTMENT OF JUSTICE, DRUG ENFORCEMENT AGENCY,
DEA's POSITION: SPEAKING OUT AGAINST DRUG LEGALIZATION (2000), at http://
www.usdoj.gov/dea/demand/druglegal/02dl.htm (last visited Jan. 20, 2002).
443. P'SH1P FOR A DRUG-FREE AM., The Wrong Message Of Legalizing Illicit
Drugs 1 (Aug. 18, 1994), at http://www.druglibrary.org/schaffer/GOVPUBS/wrongl.
htm (last visited Apr. 24, 2002).
444. Subcommittee on Criminal Justice, Drug Policy and Harm Resources, Com-
mittee on Government Reform, Testimony Before the House Government Reform
and Oversight Committee (Jul. 13, 1999), at http://www.house.gov/reform/cj/hearings/
99.7.13/maccoun.htm (last visited Jan. 20, 2002) (hypothesizing about the results of
legalization of cocaine and heroin).
445. Id.
446. Supra note 7 and accompanying text (exploring the fears that drive the current
drug policy); supra notes 14-17 and accompanying text (discussing the economic and
social costs of the war on drugs); see also supra notes 34-51 and accompanying text
(summarizing Ecstasy facts and policy).
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ment.447 The harms caused by Ecstasy, like other drugs, are social
and public health harms that should be addressed primarily by
medical and scientific professionals.448 Prominent scientists and
physicians have cautioned against implementing strict penalties for
Ecstasy since the scheduling hearings in 1984. 449 Yet, legislators
have unsuccessfully attempted to control Ecstasy use and traffick-
ing for the past fifteen years through the punitive criminal justice
approach. After years of failed attempts, legislators should realize
that Ecstasy policy is complex and calls for a nuanced approach.45 °
A hybrid plan, combining several elements of the various ap-
proaches that have been explored in this Comment, will more ef-
fectively address health, safety, and crime reduction goals.
First, Ecstasy should be reclassified as a schedule III substance
so that research and medical use will be permitted. Second, the
federal penalties for Ecstasy trafficking should be reduced. Third,
Ecstasy should be decriminalized nationally to encourage users to
seek out harm reduction services without fear of arrest. Finally,
the national drug control budget should be revised to allocate sig-
nificantly more drug control funding to government and private
sponsored harm reduction methods, including various types of pre-
vention education, treatment, and safer-use programs.
A. Ecstasy Should Be Reclassified as a Schedule III Substance
Reclassifying Ecstasy as a schedule III substance would allow for
research on humans that could further illuminate potential medical
447. Supra notes 36-38 and accompanying text (citing statistics demonstrating the
increase in use of Ecstasy); supra notes 43-47 and accompanying text (discussing the
increase in penalties by legislators and the scientific confusion about the effects of
Ecstasy).
448. Supra note 350 and accompanying text (presenting the view that drug use is a
public health issue that should be addressed by public health professionals).
449. Supra notes 247-50 and accompanying text (describing the hearing process and
the large number of witnesses and submissions from the medical and scientific
communities).
450. Although this Comment has focused on federal laws, drug offenses are often
treated differently from state-to-state. See ImpacTeen Illicit Drug Team, Illicit Drug
Policies: Selected Laws from the 50 States (Andrews University 2002), at http://
www.andrews.edu/BHSC/inpacteen-illicitdrugteam/index.php (last visited Apr. 24,
2002). States play an important role in the war on drugs. New Study Provides First
Comprehensive Report on Drug Laws in All 50 States and DC, Variations Abound,
The Week Online with DRCNet, Feb, 22, 2002, at http://www.drcnet.org/wol/225.html
(quoting Dr. Jamie Chriqui, lead author of the report) (last visited Apr. 24, 2002).
Since states play such an important role, federal reform as advocated in this Comment
may be most effective if also accompanied by vast state reform in the same vein.
2186
AGONY OF ECSTASY
uses and the dangers of Ecstasy use.45 1 The reasons the DEA's
ALJ recommended schedule III placement are still compelling: Ec-
stasy has an accepted medical use; under medical supervision, Ec-
stasy administration meets acceptable safety parameters; and
Ecstasy has less than a high potential for abuse. 52 As the First
Circuit Court of Appeals held, FDA approval is not dispositive of a
substance having an "accepted medical use." '453 However, the ther-
apists who used Ecstasy on their patients reported great benefits
when it was used within acceptable safety standards.454 In fact, the
serotonin damage reported in some studies is almost identical to
that done by the once widely used appetite suppressant, fen-
fluramine, yet that drug earned FDA approval.455 Recent studies
support the finding that Ecstasy's potential addictive power is only
psychological, which should place the drug in schedule 111.456
Reclassification of Ecstasy as a schedule III substance would be
advantageous from a health and safety perspective because it
would ease the restrictions on human research that perpetuate the
confusion over Ecstasy's medical effects.4 57 The dispute among
scientists over the long-term effects of Ecstasy, together with the
increasing number of younger users, illustrate the need for further
research that is objective and thorough.458 While the abstinence-
only approach to prevention touting the dangers of Ecstasy use
drives the reported results of government-sanctioned research,459
objective research will lead to a more effective, reality-based policy
that will likely result in more young people paying attention to risk
451. Supra notes 310-20 and accompanying text (discussing the administrative bar-
riers to research as a result of Ecstasy's schedule I placement and the need for objec-
tive research).
452. Supra notes 257-59 and accompanying text (explaining the ALJ's ruling that
Ecstasy should be classified as a schedule III substance).
453. Grinspoon v. DEA, 828 F.2d 881, 891 (1st Cir. 1987).
454. Grob, supra note 218, at 560 (discussing the positive results obtained in con-
trolled therapeutic settings).
455. See id. at 564 ("Fenfluramine has also been known for years to have virtually
identical long-term effects as Ecstasy on serotonin neurochemistry and neuronal
architecture.").
456. See BECK & ROSENBAUM, supra note 112, at 113-29 (stating that the abuse
potential of Ecstasy is low and discussing factors that contribute to abuse among
users).
457. See Grob, supra note 44, at 580-81 (discussing the obstacles to a controlled
MDMA study on humans and the need for objective data).
458. Supra notes 228-36 and accompanying text (discussing contradictory Ecstasy
research).
459. Supra notes 46-47 and accompanying text.
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warnings.46 ° Such research can be conducted only if Ecstasy is re-
classified as a schedule III substance.
B. Federal Sentences For Ecstasy Trafficking Should
Be Reduced
The sentencing requirements for Ecstasy under the Federal Sen-
tencing Guidelines should be reduced to preamendment levels," 1
which were lower than the sentences for cocaine.462 Although the
Commission has cited certain findings as the bases for its decision
to increase Ecstasy sentences, it considered a significant amount of
conflicting information when making the decision and has not ex-
plained why it chose to find only certain facts persuasive. For ex-
ample, Ecstasy's neurotoxicity is unresolved within the scientific
community. 463 Many experts have commented that Ecstasy is gen-
erally less dangerous than other drugs;464 however, the Commission
found conclusively that Ecstasy is neurotoxic.465 The Commission
also failed to find any evidence to suggest that Ecstasy causes the
same harms as other regularly abused drugs.466 Moreover, this fail-
ure was apparently not factored into the decision to increase Ec-
stasy sentences. 467 In making its decision, the Commission also
considered legislative history indicating that there was congres-
sional concern over the dramatic surge in the use of Ecstasy. 468 It
is highly likely that congressional influence affected the Commis-
sion's findings, and this effect demonstrates the conflict of interests
in federal drug policy implementation.
The economic costs and societal harms that will result from in-
creased sentences outweigh the dubious deterrent effect they may
460. Supra notes 46-47 and accompanying text (discussing teenagers' mistrust of
abstinence-only advertisements); see also supra notes 228-42 and accompanying text
(discussing contradictory Ecstasy research and a misleading scare-tactic television
special).
461. Supra notes 283-87 and accompanying text (explaining the 2001 sentencing
increases).
462. Supra notes 283-91 and accompanying text (discussing the evidence considered
in the process of increasing Ecstasy sentences).
463. Supra notes 221-36 and accompanying text (discussing the scientific dispute
about Ecstasy's neurotoxicity).
464. U.S. SENTENCING COMM'N, supra note 46, at 18.
465. Id.
466. Id.
467. Id. at 18-19. This fact could have been considered in the decision not to in-
crease penalties to be equal to those for heroin trafficking.
468. Id. at 16 ("Congressional activity indicates that Congress is concerned over the
surge in use of Ecstasy and other club drugs.").
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offer, especially given the potential profits of Ecstasy trafficking.469
When the Federation of American Scientists finds there is "no jus-
tification, either pharmacologically or in policy terms" for in-
creased Ecstasy penalties, lawmakers should listen.470 The
disregard by Congress and the DEA of all but a few Government
scientists indicates the level of bias in the formation of Ecstasy
policy.
C. Ecstasy Shduld be Further Decriminalized
Ecstasy decriminalization, already occurring at the local level,
should be clarified and broadened nationally.471 Absent the fear of
arrest, more people will take advantage of safer-use472 programs.473
The argument that decriminalization is tacit approval of illicit drug
use can be countered with the assertion that "Penalties for posses-
sion of a drug should not be more harmful to the individual than
the use of the drug itself. ' 474 Authorities still debate what harm is
caused by Ecstasy 475 and have not assessed the harm if safer-use
programs are followed.476 Given that the harm caused by strict
criminal sanctions is severe,477 enforcement of Ecstasy possession
laws may cause more harm than does the use of Ecstasy.
D. The Drug Control Budget Should Prioritize Harm
Reduction Methods
The national drug control budget should be revised to allocate
significantly more drug control funding to government and private-
sponsored harm reduction methods, including effective prevention
education, treatment, and safer-use programs. More of the funding
that is currently earmarked for enforcement efforts should be allo-
cated to these programmatic harm reduction solutions.478 If the
469. Supra notes 339-45 and accompanying text (discussing the U.S. Sentencing
Commission's prison impact model and the other societal harms of the increased Ec-
stasy penalties).
470. Press Release, The Lindesmith Center, Harsh New Federal Penalties for Ec-
stasy Take Effect (Apr. 30, 2001) (on file with author).
471. Supra notes 426-32 and accompanying text (discussing decriminalization as ap-
plied to Ecstasy).
472. Supra notes 403-20 and accompanying text.
473. Supra note 431 and accompanying text.
474. GRAY, supra note 1, at 219 (quoting former President Jimmy Carter).
475. For a complete discussion of the potential harms caused by Ecstasy use, see
supra notes 214-246 and accompanying text.
476. Supra notes 403-20 and accompanying text.
477. Supra notes 14-19 and accompanying text.
478. For an explanation of the current drug control budget, see supra note 17.
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Administration's main concern is the safety of those using Ecstasy,
primarily young people, then funds should be allocated to efforts
that will improve their safety and health.
Most of the current budget allotted to prevention efforts goes to
either DARE or LST,479 despite the demonstrated ineffectiveness
of abstinence-only education.4 80 Such programs should be discon-
tinued and replaced with a combination of resilience education and
student assistance programs.481 This combination would meet the
goals set forth by NIDA: enhancing protective factors and reducing
risk factors.482
Funds should also be allocated to treatment programs because
the field of Ecstasy treatment is in its infancy.483 Treatment should
involve the continuing education of hospital and emergency room
personnel to ensure that patients under the influence of Ecstasy
are treated properly and that they provide only voluntary counsel-
ing and/or abstinence treatment.484 Although Ecstasy addiction is
not a physical condition requiring medical attention,485 dependency
and abuse can still occur, and some abusive Ecstasy users may want
to achieve abstinence.486 Given the cost-effectiveness of treatment
programs, allocating funding for Ecstasy treatment simply makes
sense.
487
If protecting public health is a priority, then safer-use pro-
grams488 should also be an integral part of Ecstasy policy. Substan-
tial anecdotal evidence establishes young people's need for both
479. Supra notes 378-91 and accompanying text (describing DARE and LST).
480. Supra notes 385-91 (explaining DARE and LST, their respective advantages
and disadvantages, and the general criticisms of abstinence-only prevention
education).
481. Supra notes 392-99 (discussing both resilience education and the Student As-
sistance Program).
482. Supra note 402 and accompanying text (explaining a NIDA study of several
prevention programs that found the qualities that make a prevention program most
effective).
483. Supra notes 367-73 and accompanying text (tracing the development of treat-
ment programs directed at Ecstasy users and how they differ from those for people
using traditionally addictive substances such as heroin and cocaine).
484. Supra notes 365-72 and accompanying text (discussing treatment options for
Ecstasy).
485. Supra note 365 and accompanying text (discussing the nonaddictive nature of
Ecstasy).
486. Supra notes 212-13 and accompanying text (explaining that Ecstasy has the
potential to become only psychologically, not physically, addictive).
487. Supra note 357 and accompanying text (explaining that treatment is seven
times more cost-effective at reducing drug use than incarceration).
488. Supra notes 403-24 and accompanying text (exploring options for Ecstasy-spe-
cific safer-use programs).
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objective information and recommendations for reducing the im-
mediate harms caused by Ecstasy use.48 9 DanceSafe's success in
preventing users from unknowingly taking pills adulterated with
substances more dangerous than Ecstasy, with the cooperation of
the police, demonstrates the need for funding of these programs.49 °
The fear that pill-testing and the dissemination of drug-risk infor-
mation implicitly condone Ecstasy use must be abandoned for the
sake of public health.49 In fact, most of the Ecstasy-related emer-
gency room visits and deaths have been the result of consumption
of adulterated pills or heat exhaustion; both of which can be easily
prevented by safer-use programs.492
CONCLUSION
The war on drugs and its latest battle on Ecstasy will be lost as
long as it is waged with prohibitionist tactics. While no solution to
Ecstasy-related problems will be flawless, a public health approach
will reduce the immediate harms that can lead to death, and will
likely resolve many of the long-term risks. At the very least, imple-
menting an approach focused on public health will allow more re-
search to be conducted, overall Ecstasy education and awareness
to increase significantly, and resources to be allocated more effi-
ciently. The price of this new approach is abandonment of the ide-
alistic belief that Ecstasy can be eradicated as a recreational drug.
Accepting that Ecstasy will be used recreationally is not surrender,
it is compromise. The time for a peaceful resolution of this war is
long overdue.
489. Supra notes 403-20 and accompanying text (discussing the need among Ec-
stasy users for safer-use information and the specific risk information that is
provided).
490. Supra notes 175-77, 431-32 and accompanying text (explaining DanceSafe's
functions); supra notes 415-20 (providing examples of DanceSafe's success in warning
Ecstasy users about the risks of adulterated Ecstasy).
491. Supra notes 421-24 and accompanying text.
492. Supra note 418 and accompanying text (discussing deaths attributed to adul-
terant PMA).
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